<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title>Antibiotics</journal-title></journal-title-group><issn pub-type="epub">2079-6382</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6022995</article-id><article-id pub-id-type="doi">10.3390/antibiotics7020041</article-id><article-id pub-id-type="publisher-id">antibiotics-07-00041</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title><italic>Streptomyces</italic> Differentiation in Liquid Cultures as a Trigger of Secondary Metabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Manteca</surname><given-names>&#x000c1;ngel</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1526-3121</contrib-id><name><surname>Yag&#x000fc;e</surname><given-names>Paula</given-names></name><xref rid="c1-antibiotics-07-00041" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-antibiotics-07-00041">&#x000c1;rea de Microbiolog&#x000ed;a, Departamento de Biolog&#x000ed;a Funcional IUOPA, Facultad de Medicina, Universidad de Oviedo, 33006 Oviedo, Spain; <email>mantecaangel@uniovi.es</email></aff><author-notes><corresp id="c1-antibiotics-07-00041"><label>*</label>Correspondence: <email>paula.yague@gmail.com</email>; Tel.: +34-9-8510-3000 (ext. 5289)</corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2018</year></pub-date><volume>7</volume><issue>2</issue><elocation-id>41</elocation-id><history><date date-type="received"><day>26</day><month>2</month><year>2018</year></date><date date-type="accepted"><day>09</day><month>5</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic>Streptomyces</italic> is a diverse group of gram-positive microorganisms characterised by a complex developmental cycle. <italic>Streptomycetes</italic> produce a number of antibiotics and other bioactive compounds used in the clinic. Most screening campaigns looking for new bioactive molecules from actinomycetes have been performed empirically, e.g., without considering whether the bacteria are growing under the best developmental conditions for secondary metabolite production. These screening campaigns were extremely productive and discovered a number of new bioactive compounds during the so-called &#x0201c;golden age of antibiotics&#x0201d; (until the 1980s). However, at present, there is a worrying bottleneck in drug discovery, and new experimental approaches are needed to improve the screening of natural actinomycetes. <italic>Streptomycetes</italic> are still the most important natural source of antibiotics and other bioactive compounds. They harbour many cryptic secondary metabolite pathways not expressed under classical laboratory cultures. Here, we review the new strategies that are being explored to overcome current challenges in drug discovery. In particular, we focus on those aimed at improving the differentiation of the antibiotic-producing mycelium stage in the laboratory.</p></abstract><kwd-group><kwd><italic>streptomyces</italic></kwd><kwd>screening</kwd><kwd>antibiotics</kwd><kwd>secondary metabolism</kwd><kwd>differentiation</kwd><kwd>elicitors</kwd><kwd>morphology</kwd><kwd>liquid cultures</kwd></kwd-group></article-meta></front><body><sec id="sec1-antibiotics-07-00041"><title>1. Introduction</title><p>The <italic>Streptomyces</italic> genus includes an important group of biotechnological bacteria. They produce two-thirds of the antibiotics of medical and agricultural interest, several antitumor agents, antifungals, and a great number of eukaryotic cell differentiation effectors, such as apoptosis inducers and inhibitors [<xref rid="B1-antibiotics-07-00041" ref-type="bibr">1</xref>]. Drug discovery from <italic>streptomycetes</italic> fell considerably after initial screenings where the most common compounds were discovered. Antibiotic resistance is increasing dramatically, and new antibiotics are urgently required in the clinic. Alternative methods, such as the exploration of chemical libraries and combinatorial chemistry, have provided limited yields. Screening from nature has resumed through methods such as exploring new environments, looking for elicitors, accessing the metagenome, etc.</p><p>One of the most important characteristics of <italic>Streptomyces</italic> is its complex life cycle, which is closely related to secondary metabolite production [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>] (outlined in <xref ref-type="fig" rid="antibiotics-07-00041-f001">Figure 1</xref>). In solid sporulating cultures, development starts with spore germination and the rapid development of compartmentalised hyphae into the medium (early substrate mycelium or MI) [<xref rid="B3-antibiotics-07-00041" ref-type="bibr">3</xref>]. After that, programmed cell death (PCD) occurs (red cellular segments in <xref ref-type="fig" rid="antibiotics-07-00041-f001">Figure 1</xref>) which triggers the differentiation of the multinucleated (MII) antibiotic-producing hyphae (late substrate mycelium, early MII) [<xref rid="B3-antibiotics-07-00041" ref-type="bibr">3</xref>,<xref rid="B4-antibiotics-07-00041" ref-type="bibr">4</xref>]. Then, the mycelium starts to grow into the air forming the aerial mycelium (late MII). At the end of the cycle, there is a second round of PCD, and most of the remaining viable hyphae undergo a process of compartmentalisation that culminates in the formation of unigenomic spores [<xref rid="B5-antibiotics-07-00041" ref-type="bibr">5</xref>].</p><p>Most <italic>streptomycetes</italic> do not sporulate in liquid cultures. Therefore, it was previously assumed that under these conditions, there was no differentiation. However, industrial antibiotic production is mostly performed in liquid cultures (flasks and bioreactors). Currently, it is known that in liquid cultures, differentiation is comparable to that observed in solid cultures (<xref ref-type="fig" rid="antibiotics-07-00041-f001">Figure 1</xref>). In liquid cultures, there is a first mycelium stage (MI), PCD and the differentiation of a secondary metabolite, producing mycelium (MII). However, in most <italic>Streptomyces</italic> strains, aerial mycelium formation and sporulation are blocked [<xref rid="B6-antibiotics-07-00041" ref-type="bibr">6</xref>] (<xref ref-type="fig" rid="antibiotics-07-00041-f001">Figure 1</xref>). <italic>S. coelicolor</italic> proteomic and transcriptomic studies have shown that physiological differentiation in liquid and solid cultures is comparable [<xref rid="B6-antibiotics-07-00041" ref-type="bibr">6</xref>,<xref rid="B7-antibiotics-07-00041" ref-type="bibr">7</xref>]. MII expresses/translates the genes/proteins involved in secondary metabolism in both solid and liquid cultures [<xref rid="B6-antibiotics-07-00041" ref-type="bibr">6</xref>,<xref rid="B7-antibiotics-07-00041" ref-type="bibr">7</xref>].</p><p>Surprisingly, <italic>Streptomyces</italic> differentiation as a trigger for antibiotic production remains almost unexplored. The absence of a developmental model to describe differentiation in liquid cultures has inhibited the understanding of the relationship between macroscopic morphology (pellet and clump formation) and differentiation. Pellet and clump formation has been classically correlated with secondary metabolite production, but the relationship between both processes remains obscure. Most authors have affirmed that pellets and clumps are fundamental for secondary metabolite production (e.g., retamycin in <italic>S. olindensis</italic> [<xref rid="B8-antibiotics-07-00041" ref-type="bibr">8</xref>], nikkomycins in <italic>S. tendae</italic> [<xref rid="B9-antibiotics-07-00041" ref-type="bibr">9</xref>], hybrid antibiotics in <italic>S. lividans</italic> [<xref rid="B10-antibiotics-07-00041" ref-type="bibr">10</xref>]), while some authors have affirmed that pellet and clump formation reduces antibiotic production (e.g., nystatin in <italic>S. noursei</italic> [<xref rid="B11-antibiotics-07-00041" ref-type="bibr">11</xref>], tylosin in <italic>S. fradiae</italic> [<xref rid="B12-antibiotics-07-00041" ref-type="bibr">12</xref>]). More recently, our group demonstrated that one of the key events in the activation of secondary metabolite production in <italic>Streptomyces</italic> liquid cultures is the differentiation of MII (e.g., actinorhodin/undecylprodigiosin production in <italic>S. coelicolor</italic> [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>,<xref rid="B13-antibiotics-07-00041" ref-type="bibr">13</xref>], microbial transglutaminase production in <italic>S. mobarensis</italic> [<xref rid="B14-antibiotics-07-00041" ref-type="bibr">14</xref>], apigenin and luteolin production in <italic>S. albus</italic> [<xref rid="B15-antibiotics-07-00041" ref-type="bibr">15</xref>]). The differentiation of this mycelium is conditioned by PCD of the vegetative hyphae (MI) [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>], which, in liquid cultures, depends on the growth rate of the strain and hypha aggregation (pellet/clump formation) [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>,<xref rid="B7-antibiotics-07-00041" ref-type="bibr">7</xref>,<xref rid="B14-antibiotics-07-00041" ref-type="bibr">14</xref>,<xref rid="B15-antibiotics-07-00041" ref-type="bibr">15</xref>,<xref rid="B16-antibiotics-07-00041" ref-type="bibr">16</xref>]. However, secondary metabolism has additional regulations (elicitors activate specific biosynthetic pathways) [<xref rid="B17-antibiotics-07-00041" ref-type="bibr">17</xref>], and most <italic>Streptomyces</italic> strains do not display all their potential secondary metabolites under standard developmental laboratory conditions, even if they are differentiated at the MII stage [<xref rid="B7-antibiotics-07-00041" ref-type="bibr">7</xref>].</p><p>Each <italic>Streptomyces</italic> strain can harbour up to 30 secondary metabolite pathways, but only a few of these are active in usual screening processes [<xref rid="B18-antibiotics-07-00041" ref-type="bibr">18</xref>]. Activating these pathways in the lab will be crucial in the process of screening for new secondary metabolites from actinomycetes. Here, we review the most important strategies that are being explored to activate cryptic pathways and/or those that are being explored to enhance secondary metabolites production.</p></sec><sec id="sec2-antibiotics-07-00041"><title>2. Screening for New Secondary Metabolites from <italic>Streptomycetes</italic></title><p>The search for new actinomycetes in unexplored niches or from the screening of strains that have not been previously cultivated is useful, but usually leads to the rediscovery of already known compounds [<xref rid="B19-antibiotics-07-00041" ref-type="bibr">19</xref>]. New screening strategies are necessary to overcome the current challenges of discovering new bioactive compounds [<xref rid="B19-antibiotics-07-00041" ref-type="bibr">19</xref>]. In 2013, Arryn Craney et al. [<xref rid="B20-antibiotics-07-00041" ref-type="bibr">20</xref>] summarised the new strategies that are being used to enhance secondary metabolite production and activate cryptic pathways, dividing them into unselective and selective methods [<xref rid="B20-antibiotics-07-00041" ref-type="bibr">20</xref>]. Unselective methods are non-specific methods that are used to screen for new activities, whereas selective methods are biosynthetic cluster-specific methods that are used to improve the production of already known molecules [<xref rid="B20-antibiotics-07-00041" ref-type="bibr">20</xref>].</p><p>Non-specific methods were largely used during &#x0201c;the golden age of antibiotics&#x0201d;, and they are still useful. These methods include classical strategies, such as changing media components, increasing general precursors (metabolic engineering), inducing stress responses (with heat/ethanol/salt/acid shock, nutrient limitations) [<xref rid="B21-antibiotics-07-00041" ref-type="bibr">21</xref>], and obtaining strains that overproduce secondary metabolites by random mutagenesis [<xref rid="B22-antibiotics-07-00041" ref-type="bibr">22</xref>,<xref rid="B23-antibiotics-07-00041" ref-type="bibr">23</xref>,<xref rid="B24-antibiotics-07-00041" ref-type="bibr">24</xref>]. More novel non-specific methods include ribosomal engineering (the alteration of ribosomal proteins to activate cryptic secondary metabolites in <italic>streptomycetes</italic>) [<xref rid="B20-antibiotics-07-00041" ref-type="bibr">20</xref>,<xref rid="B25-antibiotics-07-00041" ref-type="bibr">25</xref>] and the use of small molecules as elicitors of secondary metabolism [<xref rid="B20-antibiotics-07-00041" ref-type="bibr">20</xref>,<xref rid="B26-antibiotics-07-00041" ref-type="bibr">26</xref>] (<xref rid="antibiotics-07-00041-t001" ref-type="table">Table 1</xref>). Differentiation of the antibiotic producer mycelium (MII) as a non-specific method to activate antibiotic production remains almost unexplored. There has been no previous analysis of the frequency of <italic>Streptomyces</italic> strains that do not produce secondary metabolites because they are not differentiated at the MII stage in the laboratory.</p><p>Biosynthetic cluster-specific methods include self-resistance engineering (upregulation of self-resistance genes), regulatory engineering (overexpression of activators or elimination of repressors) and genome mining to search for new biosynthetic pathways [<xref rid="B20-antibiotics-07-00041" ref-type="bibr">20</xref>] (<xref rid="antibiotics-07-00041-t002" ref-type="table">Table 2</xref>). One of the most important biosynthetic cluster-specific methods is heterologous expression. Heterologous expression has been used to express <italic>Streptomyces</italic> industrial enzymes, such as laccases, in microorganisms with simpler developmental cycles than <italic>Streptomyces</italic>, such as <italic>E. coli</italic> [<xref rid="B27-antibiotics-07-00041" ref-type="bibr">27</xref>]. However, the complex biosynthetic pathways of <italic>Streptomyces</italic> rarely can be expressed in simple expression hosts, such as <italic>E. coli</italic> or <italic>Bacillus</italic>. Thus, other <italic>streptomycetes</italic>, such as <italic>S. lividans</italic>, <italic>S. albus</italic>, <italic>S. coelicolor</italic> or <italic>S. avermitilis</italic>, are commonly used as expression hosts [<xref rid="B28-antibiotics-07-00041" ref-type="bibr">28</xref>]. The activation of cryptic metabolites through the expression of the <italic>Streptomyces coelicolor</italic> pleiotropic regulator, <italic>Afs</italic>Q, in other <italic>streptomycetes</italic> [<xref rid="B29-antibiotics-07-00041" ref-type="bibr">29</xref>] has been successfully achieved. Combinatorial biosynthesis, chemical modification of existing molecules, has been largely developed over the last 20 years, in particular, progress has been made in the last few years thanks to genome mining and synthetic biology [<xref rid="B30-antibiotics-07-00041" ref-type="bibr">30</xref>,<xref rid="B31-antibiotics-07-00041" ref-type="bibr">31</xref>,<xref rid="B32-antibiotics-07-00041" ref-type="bibr">32</xref>]. Differentiation of <italic>Streptomyces</italic> MII was successfully used to enhance the production of various products [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>,<xref rid="B13-antibiotics-07-00041" ref-type="bibr">13</xref>,<xref rid="B14-antibiotics-07-00041" ref-type="bibr">14</xref>,<xref rid="B15-antibiotics-07-00041" ref-type="bibr">15</xref>] through its role as a trigger for antibiotic production (described in <xref ref-type="sec" rid="sec2dot3-antibiotics-07-00041">Section 2.3</xref>).</p><sec id="sec2dot1-antibiotics-07-00041"><title>2.1. Streptomyces Differentiation Strategies Based on Elicitors</title><p>In the last few years, effort has been made to elucidate the mechanism by which some small molecules (elicitors) affect differentiation and secondary metabolite production in <italic>Streptomyces</italic> strains. Elicitors can be defined as diffusible signals that are able to induce cryptic pathways and/or differentiation in <italic>Streptomyces</italic> cultures [<xref rid="B17-antibiotics-07-00041" ref-type="bibr">17</xref>]. Some elicitors act as signals for interspecies interaction [<xref rid="B33-antibiotics-07-00041" ref-type="bibr">33</xref>]. Thus, subinhibitory concentrations of certain antibiotics produced by a given <italic>Streptomyces</italic> strain accelerate differentiation and antibiotic production in other <italic>Streptomyces</italic> strains through &#x0201c;pseudo&#x0201d; gamma-butyrolactone receptors [<xref rid="B33-antibiotics-07-00041" ref-type="bibr">33</xref>]. Another good strategy is the use of random chemical probes (natural or synthetic) as elicitors (reviewed in [<xref rid="B21-antibiotics-07-00041" ref-type="bibr">21</xref>]).</p><p>One of the most common strategies used to activate secondary metabolism and differentiation is mimicking the ecological environment through co-cultures of different microbes [<xref rid="B17-antibiotics-07-00041" ref-type="bibr">17</xref>,<xref rid="B34-antibiotics-07-00041" ref-type="bibr">34</xref>]. This methodology typically uses species that have symbiotic relationships with <italic>Streptomyces</italic> in nature [<xref rid="B35-antibiotics-07-00041" ref-type="bibr">35</xref>,<xref rid="B36-antibiotics-07-00041" ref-type="bibr">36</xref>] or pathogen partners that activate the production of antimicrobial compounds [<xref rid="B37-antibiotics-07-00041" ref-type="bibr">37</xref>,<xref rid="B38-antibiotics-07-00041" ref-type="bibr">38</xref>,<xref rid="B39-antibiotics-07-00041" ref-type="bibr">39</xref>]. For instance, fungal elicitors (complex mix of cell walls and filtered cultures) positively affect the production of natamycin [<xref rid="B40-antibiotics-07-00041" ref-type="bibr">40</xref>], bacterial and yeast elicitors improve valinomycin production [<xref rid="B41-antibiotics-07-00041" ref-type="bibr">41</xref>], nutrients such as glucose and xylose repress the production of actinorhodin [<xref rid="B42-antibiotics-07-00041" ref-type="bibr">42</xref>,<xref rid="B43-antibiotics-07-00041" ref-type="bibr">43</xref>], and small molecules, such as GlcNAc or phosphate, can trigger differentiation and antibiotic production in <italic>S. coelicolor</italic> through the activation of <italic>act</italic>II-ORF4/<italic>red</italic>Z genes [<xref rid="B44-antibiotics-07-00041" ref-type="bibr">44</xref>].</p><p>Pimentel-Elardo et al. [<xref rid="B45-antibiotics-07-00041" ref-type="bibr">45</xref>] developed an activity-independent screening method based on the use of elicitors, to prevent the rediscovery of the most active/abundant compounds. In addition, cheminformatics techniques are used to identify the putative biological activities of identified compounds [<xref rid="B45-antibiotics-07-00041" ref-type="bibr">45</xref>]. The use of elicitors increases the production of low-abundant compounds which were undetected in the classical activity dependent screening. The chemical elicitor &#x0201c;CI-ARC&#x0201d; has been identified as being responsible for triggering several cryptic biosynthetic genes [<xref rid="B45-antibiotics-07-00041" ref-type="bibr">45</xref>].</p></sec><sec id="sec2dot2-antibiotics-07-00041"><title>2.2. Differentiation Strategies Based on Macroscopic Morphology</title><sec id="sec2dot2dot1-antibiotics-07-00041"><title>2.2.1. The Genetic Control of Aggregation and Macroscopic Morphology in Liquid Cultures</title><p>Large-scale antibiotic production is mostly performed in liquid cultures. It is almost unanimously accepted that the macroscopic morphology of the mycelium (pellets and clump formation) is correlated with the production of secondary metabolites. However, it was not until recently that the genes controlling pellet and clump formation have been characterised. The <italic>S. coelicolor mat</italic> gene cluster [<xref rid="B46-antibiotics-07-00041" ref-type="bibr">46</xref>] and the <italic>cslA</italic>, <italic>glxA</italic>, <italic>dtpA</italic> genes [<xref rid="B47-antibiotics-07-00041" ref-type="bibr">47</xref>,<xref rid="B48-antibiotics-07-00041" ref-type="bibr">48</xref>,<xref rid="B49-antibiotics-07-00041" ref-type="bibr">49</xref>] are responsible for mycelial aggregation and pellet formation. These genes could be a great tool for controlling the morphology in industrial fermentation.</p><p>The <italic>Streptomyces</italic> life cycle in liquid cultures starts with the germination of spores. Awakening from the dormant spore state depends on the level of AMPc in the cultures [<xref rid="B50-antibiotics-07-00041" ref-type="bibr">50</xref>] and involves the small hydrophobic protein NepA, [<xref rid="B51-antibiotics-07-00041" ref-type="bibr">51</xref>]. The expression of several sigma factors involved in osmotic and oxidative stress (SigH, SigB, SigI, SigJ) undergoes remarkable changes during germination, indicating that germination evokes stress-like cell responses [<xref rid="B52-antibiotics-07-00041" ref-type="bibr">52</xref>]. Several genes encoding proteins involved in lipid metabolism and membrane transport are overexpressed during germination [<xref rid="B52-antibiotics-07-00041" ref-type="bibr">52</xref>]. The conservation of <sc>d</sc>-alanyl-<sc>d</sc>-alanine carboxypeptidase (SCO4439) contributes to the swelling phase of germination [<xref rid="B53-antibiotics-07-00041" ref-type="bibr">53</xref>]. Cell wall hydrolases participate in germination [<xref rid="B54-antibiotics-07-00041" ref-type="bibr">54</xref>]. SsgA protein marks the germinative tube emission points [<xref rid="B55-antibiotics-07-00041" ref-type="bibr">55</xref>]. Recently it was described that during germination, spores aggregate due to extracellular glycans synthesized by the MatA, MatB [<xref rid="B46-antibiotics-07-00041" ref-type="bibr">46</xref>,<xref rid="B56-antibiotics-07-00041" ref-type="bibr">56</xref>] and the CslA/GlxA/DtpA proteins [<xref rid="B56-antibiotics-07-00041" ref-type="bibr">56</xref>]. These aggregates determine the macroscopic morphology (pellets and clumps) of the culture [<xref rid="B56-antibiotics-07-00041" ref-type="bibr">56</xref>] which triggers PCD and the physiological differentiation of the antibiotic producer, mycelium MII [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>].</p><p>Another issue that influence secondary metabolite production is sporulation. Several <italic>streptomycetes</italic> are able to sporulate in liquid cultures [<xref rid="B57-antibiotics-07-00041" ref-type="bibr">57</xref>] and some strains, that normally do not sporulate are also able to sporulate in bioreactors due to the stress generated in the fermenter [<xref rid="B13-antibiotics-07-00041" ref-type="bibr">13</xref>]. Sporulation stops metabolism, including secondary metabolite production. Consequently, in industrial fermentations and during screening for new secondary metabolites, it is important to avoid sporulation to increase and maintain secondary metabolism for as long as possible [<xref rid="B13-antibiotics-07-00041" ref-type="bibr">13</xref>].</p></sec><sec id="sec2dot2dot2-antibiotics-07-00041"><title>2.2.2. Monitoring of <italic>Streptomyces</italic> Macroscopic Morphology and Differentiation in Liquid Cultures</title><p>Pellet and clump formation led to differentiation and secondary metabolism [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>]. Consequently, new methodologies to monitor macroscopic morphology have been developed. Laser diffraction has been used to measure pellet size [<xref rid="B58-antibiotics-07-00041" ref-type="bibr">58</xref>]. Flow cytometry has been used to establish pellet size distribution of culture populations [<xref rid="B59-antibiotics-07-00041" ref-type="bibr">59</xref>,<xref rid="B60-antibiotics-07-00041" ref-type="bibr">60</xref>]. Recently, a useful algorithm was developed as a plug-in for the open-source software, ImageJ, to characterize the morphology of filamentous microorganisms in liquid cultures [<xref rid="B61-antibiotics-07-00041" ref-type="bibr">61</xref>]. Mathematical models have been performed to predict the behaviour of <italic>Streptomyces</italic> liquid cultures based on pellet/clump morphology [<xref rid="B62-antibiotics-07-00041" ref-type="bibr">62</xref>,<xref rid="B63-antibiotics-07-00041" ref-type="bibr">63</xref>].</p><p>Biophysical parameters (e.g., pH, viscosity, agitation, dissolved oxygen levels and surface tension, among others) directly affect morphology and differentiation [<xref rid="B13-antibiotics-07-00041" ref-type="bibr">13</xref>,<xref rid="B64-antibiotics-07-00041" ref-type="bibr">64</xref>]. These parameters must be considered when scaling up production to industrial conditions [<xref rid="B65-antibiotics-07-00041" ref-type="bibr">65</xref>]. Interestingly, a recent study downscaled liquid cultures to the 100 &#x000b5;L scale in microtiter plates [<xref rid="B66-antibiotics-07-00041" ref-type="bibr">66</xref>], reproducing the same range of production and morphology as large-scale bioreactors, making screening easier and facilitating further upscaling.</p></sec><sec id="sec2dot2dot3-antibiotics-07-00041"><title>2.2.3. Macroscopic Morphology Conditions, Programmed Cell Death and Second Mycelium Differentiation in Liquid Cultures</title><p>PCD is the key event that triggers the differentiation of the antibiotic producer, mycelium (MII), in liquid and solid cultures [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>]. However, the specific signals derived from cell death are not yet known. The production of <italic>N</italic>-acetylglucosamine from peptidoglycan dismantling accelerates development and antibiotic production [<xref rid="B67-antibiotics-07-00041" ref-type="bibr">67</xref>,<xref rid="B68-antibiotics-07-00041" ref-type="bibr">68</xref>] and might be one of the signals released during PCD.</p><p>A simple methodology based on fluorometric measures of cultures stained with SYTO9 and propidium iodide was designed to quantify PCD in liquid cultures [<xref rid="B69-antibiotics-07-00041" ref-type="bibr">69</xref>]. This method allows the efficiency of antibiotic production to be predicted based on the level of PCD [<xref rid="B69-antibiotics-07-00041" ref-type="bibr">69</xref>].</p><p>Strains showing dispersed growth take a long time to suffer PCD, and sometimes, PCD does not occur. Modify the developmental conditions to enhance PCD and MII differentiation, leads to an improvement in secondary metabolite production. This approach was recently applied to enhance flavonoid production in a strain of <italic>Streptomyces albus</italic> [<xref rid="B15-antibiotics-07-00041" ref-type="bibr">15</xref>] and to enhance microbial transglutaminase production from <italic>Streptomyces mobaraensis</italic> [<xref rid="B14-antibiotics-07-00041" ref-type="bibr">14</xref>]. The &#x0201c;PCD-MII&#x0201d; approach complements other approaches well; there is no secondary metabolite production without differentiation of MII, but there are biosynthetic pathways that in addition to MII differentiation, need specific elicitors to become active [<xref rid="B70-antibiotics-07-00041" ref-type="bibr">70</xref>].</p></sec></sec><sec id="sec2dot3-antibiotics-07-00041"><title>2.3. L-Forms</title><p>An interesting alternative that would avoid the problems of mycelial growth in industry, is the use of L-forms, which are individual cells without cell walls [<xref rid="B71-antibiotics-07-00041" ref-type="bibr">71</xref>]. However, until now, the antibiotic levels reached by <italic>Streptomyces</italic> L-forms have been quite minor compared to those reached by the regular form. Therefore, future research should explore whether L-forms could offer an industrial alternative.</p></sec><sec id="sec2dot4-antibiotics-07-00041"><title>2.4. Other Strategies</title><p>A big challenge in screening for new secondary metabolites is exploring non-cultivated bacteria. The scientific community is aware of the huge quantity of microorganisms that are not cultivated under laboratory conditions. Next Generation Sequencing revealed the big pharmacological potential of uncultured bacteria. Innovative culturing techniques, such as the isolation chip (iChip), are being used successfully in combination with co-cultures to grow previously uncultured bacteria [<xref rid="B72-antibiotics-07-00041" ref-type="bibr">72</xref>]. The study of unexplored niches to look for new Actinomycetes is another strategy that enables the discovery of new species and compounds [<xref rid="B73-antibiotics-07-00041" ref-type="bibr">73</xref>,<xref rid="B74-antibiotics-07-00041" ref-type="bibr">74</xref>,<xref rid="B75-antibiotics-07-00041" ref-type="bibr">75</xref>]. The combination of these two methods is a promising strategy to identify new compounds.</p><p>One of the newest strategies focusses on primary metabolism and vegetative growth. Very recently, work by Schniete et al. [<xref rid="B76-antibiotics-07-00041" ref-type="bibr">76</xref>] showed how genetic redundancy within actinobacterial genomes allows functional specialization of two pyruvate kinases in <italic>Streptomyces</italic> under different life cycle stages and environmental conditions. Genetic redundancy within actinobacteria genomes as being a key to understanding how the plasticity of this microorganism enhances the production of clinically useful molecules. Furthermore, Cihak et al. [<xref rid="B77-antibiotics-07-00041" ref-type="bibr">77</xref>] recently described the production of secondary metabolites during germination in <italic>Streptomyces coelicolor</italic>. The germination stage was ignored in most secondary metabolite screening campaigns and constitutes a potential source of bioactive compounds to be explored [<xref rid="B77-antibiotics-07-00041" ref-type="bibr">77</xref>].</p></sec></sec><sec id="sec3-antibiotics-07-00041"><title>3. Conclusions</title><p>We generally face the great challenge of fighting antibiotic resistance, which is growing much faster than our capacity to find new antimicrobials and new strategies to face this problem. The <italic>Streptomyces</italic> genus is still a huge source of natural bioactive compounds, but we need to form new strategies to avoid rediscovering compounds. There is not a single methodology to trigger differentiation, activate cryptic secondary metabolism pathways and improve the discovery of new bioactive compounds. However, the multidisciplinary biosynthetic cluster specific and non-specific approaches discussed in this manuscript, will be key to improving the screening for new secondary metabolites from <italic>streptomycetes</italic>.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank the Spanish &#x0201c;Ministerio de Econom&#x000ed;a y Competitividad&#x0201d; (MINECO; BIO2015-65709-R) for financial support.</p></ack><notes><title>Author Contributions</title><p>P.Y. planned the topic of the review and searched the information; A.M. and P.Y. wrote the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-antibiotics-07-00041"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worrall</surname><given-names>J.A.</given-names></name><name><surname>Vijgenboom</surname><given-names>E.</given-names></name></person-group><article-title>Copper mining in <italic>streptomyces</italic>: Enzymes, natural products and development</article-title><source>Nat. Prod. Rep.</source><year>2010</year><volume>27</volume><fpage>742</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1039/b804465c</pub-id><?supplied-pmid 20372697?><pub-id pub-id-type="pmid">20372697</pub-id></element-citation></ref><ref id="B2-antibiotics-07-00041"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manteca</surname><given-names>A.</given-names></name><name><surname>Alvarez</surname><given-names>R.</given-names></name><name><surname>Salazar</surname><given-names>N.</given-names></name><name><surname>Yague</surname><given-names>P.</given-names></name><name><surname>Sanchez</surname><given-names>J.</given-names></name></person-group><article-title>Mycelium differentiation and antibiotic production in submerged cultures of <italic>Streptomyces coelicolor</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2008</year><volume>74</volume><fpage>3877</fpage><lpage>3886</lpage><pub-id pub-id-type="doi">10.1128/AEM.02715-07</pub-id><?supplied-pmid 18441105?><pub-id pub-id-type="pmid">18441105</pub-id></element-citation></ref><ref id="B3-antibiotics-07-00041"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yague</surname><given-names>P.</given-names></name><name><surname>Willemse</surname><given-names>J.</given-names></name><name><surname>Koning</surname><given-names>R.I.</given-names></name><name><surname>Rioseras</surname><given-names>B.</given-names></name><name><surname>Lopez-Garcia</surname><given-names>M.T.</given-names></name><name><surname>Gonzalez-Quinonez</surname><given-names>N.</given-names></name><name><surname>Lopez-Iglesias</surname><given-names>C.</given-names></name><name><surname>Shliaha</surname><given-names>P.V.</given-names></name><name><surname>Rogowska-Wrzesinska</surname><given-names>A.</given-names></name><name><surname>Koster</surname><given-names>A.J.</given-names></name><etal/></person-group><article-title>Subcompartmentalization by cross-membranes during early growth of <italic>streptomyces</italic> hyphae</article-title><source>Nat. Commun.</source><year>2016</year><volume>7</volume><fpage>12467</fpage><pub-id pub-id-type="doi">10.1038/ncomms12467</pub-id><?supplied-pmid 27514833?><pub-id pub-id-type="pmid">27514833</pub-id></element-citation></ref><ref id="B4-antibiotics-07-00041"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manteca</surname><given-names>A.</given-names></name><name><surname>Fernandez</surname><given-names>M.</given-names></name><name><surname>Sanchez</surname><given-names>J.</given-names></name></person-group><article-title>A death round affecting a young compartmentalized mycelium precedes aerial mycelium dismantling in confluent surface cultures of <italic>streptomyces</italic> antibioticus</article-title><source>Microbiology</source><year>2005</year><volume>151</volume><fpage>3689</fpage><lpage>3697</lpage><pub-id pub-id-type="doi">10.1099/mic.0.28045-0</pub-id><?supplied-pmid 16272390?><pub-id pub-id-type="pmid">16272390</pub-id></element-citation></ref><ref id="B5-antibiotics-07-00041"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flardh</surname><given-names>K.</given-names></name></person-group><article-title>Growth polarity and cell division in <italic>streptomyces</italic></article-title><source>Curr. Opin. Microbiol.</source><year>2003</year><volume>6</volume><fpage>564</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2003.10.011</pub-id><?supplied-pmid 14662351?><pub-id pub-id-type="pmid">14662351</pub-id></element-citation></ref><ref id="B6-antibiotics-07-00041"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manteca</surname><given-names>A.</given-names></name><name><surname>Jung</surname><given-names>H.R.</given-names></name><name><surname>Schwammle</surname><given-names>V.</given-names></name><name><surname>Jensen</surname><given-names>O.N.</given-names></name><name><surname>Sanchez</surname><given-names>J.</given-names></name></person-group><article-title>Quantitative proteome analysis of <italic>Streptomyces coelicolor</italic> nonsporulating liquid cultures demonstrates a complex differentiation process comparable to that occurring in sporulating solid cultures</article-title><source>J. Proteome Res.</source><year>2010</year><volume>9</volume><fpage>4801</fpage><lpage>4811</lpage><pub-id pub-id-type="doi">10.1021/pr100513p</pub-id><?supplied-pmid 20681593?><pub-id pub-id-type="pmid">20681593</pub-id></element-citation></ref><ref id="B7-antibiotics-07-00041"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yague</surname><given-names>P.</given-names></name><name><surname>Rodriguez-Garcia</surname><given-names>A.</given-names></name><name><surname>Lopez-Garcia</surname><given-names>M.T.</given-names></name><name><surname>Rioseras</surname><given-names>B.</given-names></name><name><surname>Martin</surname><given-names>J.F.</given-names></name><name><surname>Sanchez</surname><given-names>J.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name></person-group><article-title>Transcriptomic analysis of liquid non-sporulating <italic>Streptomyces coelicolor</italic> cultures demonstrates the existence of a complex differentiation comparable to that occurring in solid sporulating cultures</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e86296</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0086296</pub-id><?supplied-pmid 24466012?><pub-id pub-id-type="pmid">24466012</pub-id></element-citation></ref><ref id="B8-antibiotics-07-00041"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giudici</surname><given-names>R.</given-names></name><name><surname>Pamboukian</surname><given-names>C.R.</given-names></name><name><surname>Facciotti</surname><given-names>M.C.</given-names></name></person-group><article-title>Morphologically structured model for antitumoral retamycin production during batch and fed-batch cultivations of streptomyces olindensis</article-title><source>Biotechnol. Bioeng.</source><year>2004</year><volume>86</volume><fpage>414</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1002/bit.20055</pub-id><?supplied-pmid 15112294?><pub-id pub-id-type="pmid">15112294</pub-id></element-citation></ref><ref id="B9-antibiotics-07-00041"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vecht-Lifshitz</surname><given-names>S.E.</given-names></name><name><surname>Sasson</surname><given-names>Y.</given-names></name><name><surname>Braun</surname><given-names>S.</given-names></name></person-group><article-title>Nikkomycin production in pellets of streptomyces tendae</article-title><source>J. Appl. Bacteriol.</source><year>1992</year><volume>72</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.1992.tb01823.x</pub-id><?supplied-pmid 1568946?><pub-id pub-id-type="pmid">1568946</pub-id></element-citation></ref><ref id="B10-antibiotics-07-00041"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarra</surname><given-names>M.</given-names></name><name><surname>Casas</surname><given-names>C.</given-names></name><name><surname>Godia</surname><given-names>F.</given-names></name></person-group><article-title>Continuous production of a hybrid antibiotic by <italic>Streptomyces lividans</italic> TK21 pellets in a three-phase fluidized-bed bioreactor</article-title><source>Biotechnol. Bioeng.</source><year>1997</year><volume>53</volume><fpage>601</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0290(19970320)53:6&#x0003c;601::AID-BIT8&#x0003e;3.0.CO;2-Q</pub-id><pub-id pub-id-type="pmid">18634061</pub-id></element-citation></ref><ref id="B11-antibiotics-07-00041"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonsbu</surname><given-names>E.</given-names></name><name><surname>McIntyre</surname><given-names>M.</given-names></name><name><surname>Nielsen</surname><given-names>J.</given-names></name></person-group><article-title>The influence of carbon sources and morphology on nystatin production by streptomyces noursei</article-title><source>J. Biotechnol.</source><year>2002</year><volume>95</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/S0168-1656(02)00003-2</pub-id><pub-id pub-id-type="pmid">11911923</pub-id></element-citation></ref><ref id="B12-antibiotics-07-00041"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Tamura</surname><given-names>S.</given-names></name><name><surname>Koike</surname><given-names>Y.</given-names></name><name><surname>Toriyama</surname><given-names>M.</given-names></name><name><surname>Okabe</surname><given-names>M.</given-names></name></person-group><article-title>Mycelial pellet intrastructure visualization and viability prediction in a culture of streptomyces fradiae using confocal scanning laser microscopy</article-title><source>J. Ferment. Bioeng.</source><year>1997</year><volume>84</volume><fpage>483</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1016/S0922-338X(97)82014-4</pub-id></element-citation></ref><ref id="B13-antibiotics-07-00041"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rioseras</surname><given-names>B.</given-names></name><name><surname>Lopez-Garcia</surname><given-names>M.T.</given-names></name><name><surname>Yague</surname><given-names>P.</given-names></name><name><surname>Sanchez</surname><given-names>J.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name></person-group><article-title>Mycelium differentiation and development of <italic>Streptomyces coelicolor</italic> in lab-scale bioreactors: Programmed cell death, differentiation, and lysis are closely linked to undecylprodigiosin and actinorhodin production</article-title><source>Bioresour. Technol.</source><year>2014</year><volume>151</volume><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2013.10.068</pub-id><?supplied-pmid 24240146?><pub-id pub-id-type="pmid">24240146</pub-id></element-citation></ref><ref id="B14-antibiotics-07-00041"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treppiccione</surname><given-names>L.</given-names></name><name><surname>Ottombrino</surname><given-names>A.</given-names></name><name><surname>Luongo</surname><given-names>D.</given-names></name><name><surname>Maurano</surname><given-names>F.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name><name><surname>Lomb&#x000f3;</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>M.</given-names></name></person-group><article-title>Development of gluten with immunomodulatory properties using mTG-active food grade supernatants from <italic>Streptomyces mobaraensis</italic> cultures</article-title><source>J. Funct. Foods</source><year>2017</year><volume>34</volume><fpage>390</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2017.05.024</pub-id></element-citation></ref><ref id="B15-antibiotics-07-00041"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>L.</given-names></name><name><surname>Gutierrez-Del-Rio</surname><given-names>I.</given-names></name><name><surname>Yague</surname><given-names>P.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name><name><surname>Villar</surname><given-names>C.J.</given-names></name><name><surname>Lombo</surname><given-names>F.</given-names></name></person-group><article-title>De novo biosynthesis of apigenin, luteolin, and eriodictyol in the actinomycete <italic>Streptomyces albus</italic> and production improvement by feeding and spore conditioning</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>921</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.00921</pub-id><?supplied-pmid 28611737?><pub-id pub-id-type="pmid">28611737</pub-id></element-citation></ref><ref id="B16-antibiotics-07-00041"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Du</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>Z.</given-names></name><name><surname>Yi</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>Enhancement of transglutaminase production in <italic>Streptomyces mobaraensis</italic> as achieved by treatment with excessive MgCl<sub>2</sub></article-title><source>Appl. Microbiol. Biotechnol.</source><year>2012</year><volume>93</volume><fpage>2335</fpage><lpage>2343</lpage><pub-id pub-id-type="doi">10.1007/s00253-011-3790-5</pub-id><?supplied-pmid 22170107?><pub-id pub-id-type="pmid">22170107</pub-id></element-citation></ref><ref id="B17-antibiotics-07-00041"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaka</surname><given-names>H.</given-names></name></person-group><article-title>Novel antibiotic screening methods to awaken silent or cryptic secondary metabolic pathways in actinomycetes</article-title><source>J. Antibiot.</source><year>2017</year><volume>70</volume><fpage>865</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1038/ja.2017.51</pub-id><?supplied-pmid 28442735?><pub-id pub-id-type="pmid">28442735</pub-id></element-citation></ref><ref id="B18-antibiotics-07-00041"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genilloud</surname><given-names>O.</given-names></name></person-group><article-title>The re-emerging role of microbial natural products in antibiotic discovery</article-title><source>Antonie Van Leeuwenhoek</source><year>2014</year><volume>106</volume><fpage>173</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1007/s10482-014-0204-6</pub-id><?supplied-pmid 24923558?><pub-id pub-id-type="pmid">24923558</pub-id></element-citation></ref><ref id="B19-antibiotics-07-00041"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genilloud</surname><given-names>O.</given-names></name></person-group><article-title>Actinomycetes: Still a source of novel antibiotics</article-title><source>Nat. Prod. Rep.</source><year>2017</year><volume>34</volume><fpage>1203</fpage><lpage>1232</lpage><pub-id pub-id-type="doi">10.1039/C7NP00026J</pub-id><?supplied-pmid 28820533?><pub-id pub-id-type="pmid">28820533</pub-id></element-citation></ref><ref id="B20-antibiotics-07-00041"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craney</surname><given-names>A.</given-names></name><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Nodwell</surname><given-names>J.</given-names></name></person-group><article-title>Towards a new science of secondary metabolism</article-title><source>J. Antibiot.</source><year>2013</year><volume>66</volume><fpage>387</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1038/ja.2013.25</pub-id><?supplied-pmid 23612726?><pub-id pub-id-type="pmid">23612726</pub-id></element-citation></ref><ref id="B21-antibiotics-07-00041"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>V.</given-names></name><name><surname>Nodwell</surname><given-names>J.R.</given-names></name></person-group><article-title>Activating secondary metabolism with stress and chemicals</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2014</year><volume>41</volume><fpage>415</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1007/s10295-013-1387-y</pub-id><?supplied-pmid 24326978?><pub-id pub-id-type="pmid">24326978</pub-id></element-citation></ref><ref id="B22-antibiotics-07-00041"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chater</surname><given-names>K.F.</given-names></name><name><surname>Ou</surname><given-names>H.Y.</given-names></name><name><surname>Xu</surname><given-names>H.H.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>Tao</surname><given-names>M.</given-names></name></person-group><article-title>Large-scale transposition mutagenesis of <italic>Streptomyces coelicolor</italic> identifies hundreds of genes influencing antibiotic biosynthesis</article-title><source>Appl. Environ. Microbiol.</source><year>2017</year><volume>83</volume><fpage>e02889-16</fpage><pub-id pub-id-type="doi">10.1128/AEM.02889-16</pub-id><?supplied-pmid 28062460?><pub-id pub-id-type="pmid">28062460</pub-id></element-citation></ref><ref id="B23-antibiotics-07-00041"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaliq</surname><given-names>S.</given-names></name><name><surname>Akhtar</surname><given-names>K.</given-names></name><name><surname>Afzal Ghauri</surname><given-names>M.</given-names></name><name><surname>Iqbal</surname><given-names>R.</given-names></name><name><surname>Mukhtar Khalid</surname><given-names>A.</given-names></name><name><surname>Muddassar</surname><given-names>M.</given-names></name></person-group><article-title>Change in colony morphology and kinetics of tylosin production after UV and gamma irradiation mutagenesis of streptomyces fradiae NRRL-2702</article-title><source>Microbiol. Res.</source><year>2009</year><volume>164</volume><fpage>469</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2007.02.005</pub-id><?supplied-pmid 17475458?><pub-id pub-id-type="pmid">17475458</pub-id></element-citation></ref><ref id="B24-antibiotics-07-00041"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korbekandi</surname><given-names>H.</given-names></name><name><surname>Darkhal</surname><given-names>P.</given-names></name><name><surname>Hojati</surname><given-names>Z.</given-names></name><name><surname>Abedi</surname><given-names>D.</given-names></name><name><surname>Hamedi</surname><given-names>J.</given-names></name><name><surname>Pourhosein</surname><given-names>M.</given-names></name></person-group><article-title>Overproduction of clavulanic acid by UV mutagenesis of <italic>Streptomyces clavuligerus</italic></article-title><source>Iran. J. Pharm. Res.</source><year>2010</year><volume>9</volume><fpage>177</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2007.07.931</pub-id><?supplied-pmid 24363725?><pub-id pub-id-type="pmid">24363725</pub-id></element-citation></ref><ref id="B25-antibiotics-07-00041"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosaka</surname><given-names>T.</given-names></name><name><surname>Ohnishi-Kameyama</surname><given-names>M.</given-names></name><name><surname>Muramatsu</surname><given-names>H.</given-names></name><name><surname>Murakami</surname><given-names>K.</given-names></name><name><surname>Tsurumi</surname><given-names>Y.</given-names></name><name><surname>Kodani</surname><given-names>S.</given-names></name><name><surname>Yoshida</surname><given-names>M.</given-names></name><name><surname>Fujie</surname><given-names>A.</given-names></name><name><surname>Ochi</surname><given-names>K.</given-names></name></person-group><article-title>Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12</article-title><source>Nat. Biotechnol.</source><year>2009</year><volume>27</volume><fpage>462</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/nbt.1538</pub-id><?supplied-pmid 19396160?><pub-id pub-id-type="pmid">19396160</pub-id></element-citation></ref><ref id="B26-antibiotics-07-00041"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>S.</given-names></name><name><surname>Craney</surname><given-names>A.</given-names></name><name><surname>Pimentel-Elardo</surname><given-names>S.M.</given-names></name><name><surname>Nodwell</surname><given-names>J.R.</given-names></name></person-group><article-title>A synthetic, speciesspecific activator of secondary metabolism and sporulation in <italic>Streptomyces coelicolor</italic></article-title><source>Chembiochem</source><year>2013</year><volume>14</volume><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1002/cbic.201200619</pub-id><?supplied-pmid 23239420?><pub-id pub-id-type="pmid">23239420</pub-id></element-citation></ref><ref id="B27-antibiotics-07-00041"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ece</surname><given-names>S.</given-names></name><name><surname>Lambertz</surname><given-names>C.</given-names></name><name><surname>Fischer</surname><given-names>R.</given-names></name><name><surname>Commandeur</surname><given-names>U.</given-names></name></person-group><article-title>Heterologous expression of a <italic>Streptomyces cyaneus</italic> laccase for biomass modification applications</article-title><source>AMB Express</source><year>2017</year><volume>7</volume><fpage>86</fpage><pub-id pub-id-type="doi">10.1186/s13568-017-0387-0</pub-id><?supplied-pmid 28439850?><pub-id pub-id-type="pmid">28439850</pub-id></element-citation></ref><ref id="B28-antibiotics-07-00041"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltz</surname><given-names>R.H.</given-names></name></person-group><article-title>Streptomyces and saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2010</year><volume>37</volume><fpage>759</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1007/s10295-010-0730-9</pub-id><?supplied-pmid 20467781?><pub-id pub-id-type="pmid">20467781</pub-id></element-citation></ref><ref id="B29-antibiotics-07-00041"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniel-Ivad</surname><given-names>M.</given-names></name><name><surname>Hameed</surname><given-names>N.</given-names></name><name><surname>Tan</surname><given-names>S.</given-names></name><name><surname>Dhanjal</surname><given-names>R.</given-names></name><name><surname>Socko</surname><given-names>D.</given-names></name><name><surname>Pak</surname><given-names>P.</given-names></name><name><surname>Gverzdys</surname><given-names>T.</given-names></name><name><surname>Elliot</surname><given-names>M.A.</given-names></name><name><surname>Nodwell</surname><given-names>J.R.</given-names></name></person-group><article-title>An engineered allele of afsQ1 facilitates the discovery and investigation of cryptic natural products</article-title><source>ACS Chem. Biol.</source><year>2017</year><volume>12</volume><fpage>628</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1021/acschembio.6b01002</pub-id><?supplied-pmid 28075554?><pub-id pub-id-type="pmid">28075554</pub-id></element-citation></ref><ref id="B30-antibiotics-07-00041"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olano</surname><given-names>C.</given-names></name><name><surname>Mendez</surname><given-names>C.</given-names></name><name><surname>Salas</surname><given-names>J.A.</given-names></name></person-group><article-title>Post-PKS tailoring steps in natural product-producing actinomycetes from the perspective of combinatorial biosynthesis</article-title><source>Nat. Prod. Rep.</source><year>2010</year><volume>27</volume><fpage>571</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.1039/b911956f</pub-id><?supplied-pmid 20352666?><pub-id pub-id-type="pmid">20352666</pub-id></element-citation></ref><ref id="B31-antibiotics-07-00041"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez</surname><given-names>A.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>M.</given-names></name><name><surname>Bra&#x000f1;a</surname><given-names>A.F.</given-names></name><name><surname>M&#x000e9;ndez</surname><given-names>C.</given-names></name><name><surname>Salas</surname><given-names>J.A.</given-names></name><name><surname>Olano</surname><given-names>C.</given-names></name></person-group><article-title>New insights into paulomycin biosynthesis pathway in <italic>Streptomyces albus</italic> j1074 and generation of novel derivatives by combinatorial biosynthesis</article-title><source>Microb. Cell Fact.</source><year>2016</year><volume>15</volume><pub-id pub-id-type="doi">10.1186/s12934-016-0452-4</pub-id><?supplied-pmid 27001601?><pub-id pub-id-type="pmid">27001601</pub-id></element-citation></ref><ref id="B32-antibiotics-07-00041"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltz</surname><given-names>R.H.</given-names></name></person-group><article-title>Synthetic biology, genome mining, and combinatorial biosynthesis of NRPS-derived antibiotics: A perspective</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2017</year><pub-id pub-id-type="doi">10.1007/s10295-017-1999-8</pub-id><?supplied-pmid 29288438?><pub-id pub-id-type="pmid">29288438</pub-id></element-citation></ref><ref id="B33-antibiotics-07-00041"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Ji</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Pan</surname><given-names>G.</given-names></name><name><surname>Fan</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name></person-group><article-title>Angucyclines as signals modulate the behaviors of <italic>Streptomyces coelicolor</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>5688</fpage><lpage>5693</lpage><pub-id pub-id-type="doi">10.1073/pnas.1324253111</pub-id><?supplied-pmid 24706927?><pub-id pub-id-type="pmid">24706927</pub-id></element-citation></ref><ref id="B34-antibiotics-07-00041"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marmann</surname><given-names>A.</given-names></name><name><surname>Aly</surname><given-names>A.H.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Co-cultivation&#x02014;A powerful emerging tool for enhancing the chemical diversity of microorganisms</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>1043</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.3390/md12021043</pub-id><?supplied-pmid 24549204?><pub-id pub-id-type="pmid">24549204</pub-id></element-citation></ref><ref id="B35-antibiotics-07-00041"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piel</surname><given-names>J.</given-names></name></person-group><article-title>Metabolites from symbiotic bacteria</article-title><source>Nat. Prod. Rep.</source><year>2004</year><volume>21</volume><fpage>519</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1039/b310175b</pub-id><?supplied-pmid 15282634?><pub-id pub-id-type="pmid">15282634</pub-id></element-citation></ref><ref id="B36-antibiotics-07-00041"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Qi</surname><given-names>X.</given-names></name></person-group><article-title>Antifungal activity change of streptomyces rimosus MY02 mediated by confront culture with other microorganism</article-title><source>J. Basic Microbiol.</source><year>2017</year><volume>57</volume><fpage>276</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1002/jobm.201600498</pub-id><?supplied-pmid 28211942?><pub-id pub-id-type="pmid">28211942</pub-id></element-citation></ref><ref id="B37-antibiotics-07-00041"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>J.</given-names></name><name><surname>Munoz-Dorado</surname><given-names>J.</given-names></name><name><surname>Brana</surname><given-names>A.F.</given-names></name><name><surname>Shimkets</surname><given-names>L.J.</given-names></name><name><surname>Sevillano</surname><given-names>L.</given-names></name><name><surname>Santamaria</surname><given-names>R.I.</given-names></name></person-group><article-title><italic>Myxococcus Xanthus</italic> induces actinorhodin overproduction and aerial mycelium formation by <italic>Streptomyces coelicolor</italic></article-title><source>Microb. Biotechnol.</source><year>2011</year><volume>4</volume><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1111/j.1751-7915.2010.00208.x</pub-id><?supplied-pmid 21342463?><pub-id pub-id-type="pmid">21342463</pub-id></element-citation></ref><ref id="B38-antibiotics-07-00041"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name><name><surname>Kong</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name></person-group><article-title>Phenolic polyketides from the co-cultivation of marine-derived <italic>Penicillium</italic> sp. Wc-29-5 and <italic>Streptomyces fradiae</italic> 007</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>2079</fpage><lpage>2088</lpage><pub-id pub-id-type="doi">10.3390/md12042079</pub-id><?supplied-pmid 24714124?><pub-id pub-id-type="pmid">24714124</pub-id></element-citation></ref><ref id="B39-antibiotics-07-00041"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>A.A.</given-names></name><name><surname>Gromek</surname><given-names>S.M.</given-names></name><name><surname>Balunas</surname><given-names>M.J.</given-names></name></person-group><article-title>Upregulation and identification of antibiotic activity of a marine-derived <italic>Streptomyces</italic> sp. Via co-cultures with human pathogens</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>250</elocation-id><pub-id pub-id-type="doi">10.3390/md15080250</pub-id><?supplied-pmid 28800088?><pub-id pub-id-type="pmid">28800088</pub-id></element-citation></ref><ref id="B40-antibiotics-07-00041"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name></person-group><article-title>Influence of fungal elicitors on biosynthesis of natamycin by streptomyces natalensis HW-2</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2013</year><volume>97</volume><fpage>5527</fpage><lpage>5534</lpage><pub-id pub-id-type="doi">10.1007/s00253-013-4786-0</pub-id><?supplied-pmid 23463250?><pub-id pub-id-type="pmid">23463250</pub-id></element-citation></ref><ref id="B41-antibiotics-07-00041"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Jamwal</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>V.P.</given-names></name><name><surname>Wazir</surname><given-names>P.</given-names></name><name><surname>Awasthi</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>D.</given-names></name><name><surname>Vishwakarma</surname><given-names>R.A.</given-names></name><name><surname>Gandhi</surname><given-names>S.G.</given-names></name><name><surname>Chaubey</surname><given-names>A.</given-names></name></person-group><article-title>Revelation and cloning of valinomycin synthetase genes in streptomyces lavendulae acr-da1 and their expression analysis under different fermentation and elicitation conditions</article-title><source>J. Biotechnol.</source><year>2017</year><volume>253</volume><fpage>40</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2017.05.008</pub-id><?supplied-pmid 28528783?><pub-id pub-id-type="pmid">28528783</pub-id></element-citation></ref><ref id="B42-antibiotics-07-00041"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gubbens</surname><given-names>J.</given-names></name><name><surname>Janus</surname><given-names>M.M.</given-names></name><name><surname>Florea</surname><given-names>B.I.</given-names></name><name><surname>Overkleeft</surname><given-names>H.S.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>Identification of glucose kinase-dependent and -independent pathways for carbon control of primary metabolism, development and antibiotic production in <italic>Streptomyces coelicolor</italic> by quantitative proteomics</article-title><source>Mol. Microbiol.</source><year>2017</year><volume>105</volume><fpage>175</fpage><pub-id pub-id-type="doi">10.1111/mmi.13714</pub-id><?supplied-pmid 28631385?><pub-id pub-id-type="pmid">28631385</pub-id></element-citation></ref><ref id="B43-antibiotics-07-00041"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.S.</given-names></name><name><surname>Yang</surname><given-names>Y.H.</given-names></name><name><surname>Song</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>E.J.</given-names></name><name><surname>Kim</surname><given-names>W.S.</given-names></name><name><surname>Sohng</surname><given-names>J.K.</given-names></name><name><surname>Lee</surname><given-names>H.C.</given-names></name><name><surname>Liou</surname><given-names>K.K.</given-names></name><name><surname>Kim</surname><given-names>B.G.</given-names></name></person-group><article-title>Mass spectrometric screening of transcriptional regulators involved in antibiotic biosynthesis in <italic>Streptomyces coelicolor</italic> A3(2)</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2009</year><volume>36</volume><fpage>1073</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1007/s10295-009-0591-2</pub-id><?supplied-pmid 19468766?><pub-id pub-id-type="pmid">19468766</pub-id></element-citation></ref><ref id="B44-antibiotics-07-00041"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Chater</surname><given-names>K.F.</given-names></name><name><surname>Chandra</surname><given-names>G.</given-names></name><name><surname>Niu</surname><given-names>G.</given-names></name><name><surname>Tan</surname><given-names>H.</given-names></name></person-group><article-title>Molecular regulation of antibiotic biosynthesis in streptomyces</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2013</year><volume>77</volume><fpage>112</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00054-12</pub-id><?supplied-pmid 23471619?><pub-id pub-id-type="pmid">23471619</pub-id></element-citation></ref><ref id="B45-antibiotics-07-00041"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pimentel-Elardo</surname><given-names>S.M.</given-names></name><name><surname>Sorensen</surname><given-names>D.</given-names></name><name><surname>Ho</surname><given-names>L.</given-names></name><name><surname>Ziko</surname><given-names>M.</given-names></name><name><surname>Bueler</surname><given-names>S.A.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Tao</surname><given-names>J.</given-names></name><name><surname>Moser</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>R.</given-names></name><name><surname>Agard</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Activity-independent discovery of secondary metabolites using chemical elicitation and cheminformatic inference</article-title><source>ACS Chem. Biol.</source><year>2015</year><volume>10</volume><fpage>2616</fpage><lpage>2623</lpage><pub-id pub-id-type="doi">10.1021/acschembio.5b00612</pub-id><?supplied-pmid 26352211?><pub-id pub-id-type="pmid">26352211</pub-id></element-citation></ref><ref id="B46-antibiotics-07-00041"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dissel</surname><given-names>D.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name><name><surname>Roth</surname><given-names>M.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>A novel locus for mycelial aggregation forms a gateway to improved streptomyces cell factories</article-title><source>Microb. Cell Fact.</source><year>2015</year><volume>14</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1186/s12934-015-0224-6</pub-id><?supplied-pmid 25889360?><pub-id pub-id-type="pmid">25889360</pub-id></element-citation></ref><ref id="B47-antibiotics-07-00041"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaplin</surname><given-names>A.K.</given-names></name><name><surname>Petrus</surname><given-names>M.L.</given-names></name><name><surname>Mangiameli</surname><given-names>G.</given-names></name><name><surname>Hough</surname><given-names>M.A.</given-names></name><name><surname>Svistunenko</surname><given-names>D.A.</given-names></name><name><surname>Nicholls</surname><given-names>P.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name><name><surname>Vijgenboom</surname><given-names>E.</given-names></name><name><surname>Worrall</surname><given-names>J.A.</given-names></name></person-group><article-title>Glxa is a new structural member of the radical copper oxidase family and is required for glycan deposition at hyphal tips and morphogenesis of <italic>Streptomyces lividans</italic></article-title><source>Biochem. J.</source><year>2015</year><volume>469</volume><fpage>433</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1042/BJ20150190</pub-id><?supplied-pmid 26205496?><pub-id pub-id-type="pmid">26205496</pub-id></element-citation></ref><ref id="B48-antibiotics-07-00041"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrus</surname><given-names>M.L.</given-names></name><name><surname>Vijgenboom</surname><given-names>E.</given-names></name><name><surname>Chaplin</surname><given-names>A.K.</given-names></name><name><surname>Worrall</surname><given-names>J.A.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name></person-group><article-title>The dyp-type peroxidase dtpa is a tat-substrate required for glxa maturation and morphogenesis in streptomyces</article-title><source>Open Biol.</source><year>2016</year><volume>6</volume><fpage>150149</fpage><pub-id pub-id-type="doi">10.1098/rsob.150149</pub-id><?supplied-pmid 26740586?><pub-id pub-id-type="pmid">26740586</pub-id></element-citation></ref><ref id="B49-antibiotics-07-00041"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrus</surname><given-names>M.L.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name></person-group><article-title>Pivotal roles for streptomyces cell surface polymers in morphological differentiation, attachment and mycelial architecture</article-title><source>Antonie Van Leeuwenhoek</source><year>2014</year><volume>106</volume><fpage>127</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1007/s10482-014-0157-9</pub-id><?supplied-pmid 24682579?><pub-id pub-id-type="pmid">24682579</pub-id></element-citation></ref><ref id="B50-antibiotics-07-00041"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susstrunk</surname><given-names>U.</given-names></name><name><surname>Pidoux</surname><given-names>J.</given-names></name><name><surname>Taubert</surname><given-names>S.</given-names></name><name><surname>Ullmann</surname><given-names>A.</given-names></name><name><surname>Thompson</surname><given-names>C.J.</given-names></name></person-group><article-title>Pleiotropic effects of camp on germination, antibiotic biosynthesis and morphological development in <italic>Streptomyces coelicolor</italic></article-title><source>Mol. Microbiol.</source><year>1998</year><volume>30</volume><fpage>33</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.1998.01033.x</pub-id><?supplied-pmid 9786183?><pub-id pub-id-type="pmid">9786183</pub-id></element-citation></ref><ref id="B51-antibiotics-07-00041"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Jong</surname><given-names>W.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name><name><surname>Sanchez</surname><given-names>J.</given-names></name><name><surname>Bucca</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>C.P.</given-names></name><name><surname>Dijkhuizen</surname><given-names>L.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name><name><surname>Wosten</surname><given-names>H.A.</given-names></name></person-group><article-title>Nepa is a structural cell wall protein involved in maintenance of spore dormancy in <italic>Streptomyces coelicolor</italic></article-title><source>Mol. Microbiol.</source><year>2009</year><volume>71</volume><fpage>1591</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06633.x</pub-id><?supplied-pmid 19222756?><pub-id pub-id-type="pmid">19222756</pub-id></element-citation></ref><ref id="B52-antibiotics-07-00041"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobek</surname><given-names>J.</given-names></name><name><surname>Strakova</surname><given-names>E.</given-names></name><name><surname>Zikova</surname><given-names>A.</given-names></name><name><surname>Vohradsky</surname><given-names>J.</given-names></name></person-group><article-title>Changes in activity of metabolic and regulatory pathways during germination of <italic>S. coelicolor</italic></article-title><source>BMC Genomics</source><year>2014</year><volume>15</volume><elocation-id>1173</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-15-1173</pub-id><?supplied-pmid 25539760?><pub-id pub-id-type="pmid">25539760</pub-id></element-citation></ref><ref id="B53-antibiotics-07-00041"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rioseras</surname><given-names>B.</given-names></name><name><surname>Yague</surname><given-names>P.</given-names></name><name><surname>Lopez-Garcia</surname><given-names>M.T.</given-names></name><name><surname>Gonzalez-Quinonez</surname><given-names>N.</given-names></name><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name></person-group><article-title>Characterization of SCO4439, a <sc>d</sc>-alanyl-<sc>d</sc>-alanine carboxypeptidase involved in spore cell wall maturation, resistance, and germination in <italic>Streptomyces coelicolor</italic></article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>21659</fpage><pub-id pub-id-type="doi">10.1038/srep21659</pub-id><?supplied-pmid 26867711?><pub-id pub-id-type="pmid">26867711</pub-id></element-citation></ref><ref id="B54-antibiotics-07-00041"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sexton</surname><given-names>D.L.</given-names></name><name><surname>St-Onge</surname><given-names>R.J.</given-names></name><name><surname>Haiser</surname><given-names>H.J.</given-names></name><name><surname>Yousef</surname><given-names>M.R.</given-names></name><name><surname>Brady</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>C.</given-names></name><name><surname>Leonard</surname><given-names>J.</given-names></name><name><surname>Elliot</surname><given-names>M.A.</given-names></name></person-group><article-title>Resuscitation-promoting factors are Cell wall-lytic enzymes with important roles in the germination and growth of <italic>Streptomyces coelicolor</italic></article-title><source>J. Bacteriol.</source><year>2015</year><volume>197</volume><fpage>848</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1128/JB.02464-14</pub-id><?supplied-pmid 25512314?><pub-id pub-id-type="pmid">25512314</pub-id></element-citation></ref><ref id="B55-antibiotics-07-00041"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noens</surname><given-names>E.E.</given-names></name><name><surname>Mersinias</surname><given-names>V.</given-names></name><name><surname>Willemse</surname><given-names>J.</given-names></name><name><surname>Traag</surname><given-names>B.A.</given-names></name><name><surname>Laing</surname><given-names>E.</given-names></name><name><surname>Chater</surname><given-names>K.F.</given-names></name><name><surname>Smith</surname><given-names>C.P.</given-names></name><name><surname>Koerten</surname><given-names>H.K.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>Loss of the controlled localization of growth stage-specific cell-wall synthesis pleiotropically affects developmental gene expression in an ssga mutant of <italic>Streptomyces coelicolor</italic></article-title><source>Mol. Microbiol.</source><year>2007</year><volume>64</volume><fpage>1244</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.05732.x</pub-id><?supplied-pmid 17542918?><pub-id pub-id-type="pmid">17542918</pub-id></element-citation></ref><ref id="B56-antibiotics-07-00041"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacchetti</surname><given-names>B.</given-names></name><name><surname>Willemse</surname><given-names>J.</given-names></name><name><surname>Recter</surname><given-names>B.</given-names></name><name><surname>van Dissel</surname><given-names>D.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name><name><surname>Wosten</surname><given-names>H.A.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name></person-group><article-title>Aggregation of germlings is a major contributing factor towards mycelial heterogeneity of <italic>streptomyces</italic></article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>27045</fpage><pub-id pub-id-type="doi">10.1038/srep27045</pub-id><?supplied-pmid 27244565?><pub-id pub-id-type="pmid">27244565</pub-id></element-citation></ref><ref id="B57-antibiotics-07-00041"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>G.</given-names></name><name><surname>Traag</surname><given-names>B.A.</given-names></name><name><surname>Sangal</surname><given-names>V.</given-names></name><name><surname>Mascini</surname><given-names>N.</given-names></name><name><surname>Hoskisson</surname><given-names>P.A.</given-names></name><name><surname>Goodfellow</surname><given-names>M.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>A novel taxonomic marker that discriminates between morphologically complex actinomycetes</article-title><source>Open Biol.</source><year>2013</year><volume>3</volume><fpage>130073</fpage><pub-id pub-id-type="doi">10.1098/rsob.130073</pub-id><?supplied-pmid 24153003?><pub-id pub-id-type="pmid">24153003</pub-id></element-citation></ref><ref id="B58-antibiotics-07-00041"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronnest</surname><given-names>N.P.</given-names></name><name><surname>Stocks</surname><given-names>S.M.</given-names></name><name><surname>Lantz</surname><given-names>A.E.</given-names></name><name><surname>Gernaey</surname><given-names>K.V.</given-names></name></person-group><article-title>Comparison of laser diffraction and image analysis for measurement of <italic>Streptomyces coelicolor</italic> cell clumps and pellets</article-title><source>Biotechnol. Lett.</source><year>2012</year><volume>34</volume><fpage>1465</fpage><lpage>1473</lpage><pub-id pub-id-type="doi">10.1007/s10529-012-0936-1</pub-id><?supplied-pmid 22538546?><pub-id pub-id-type="pmid">22538546</pub-id></element-citation></ref><ref id="B59-antibiotics-07-00041"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Veluw</surname><given-names>G.J.</given-names></name><name><surname>Petrus</surname><given-names>M.L.</given-names></name><name><surname>Gubbens</surname><given-names>J.</given-names></name><name><surname>de Graaf</surname><given-names>R.</given-names></name><name><surname>de Jong</surname><given-names>I.P.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name><name><surname>Wosten</surname><given-names>H.A.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name></person-group><article-title>Analysis of two distinct mycelial populations in liquid-grown streptomyces cultures using a flow cytometry-based proteomics approach</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2012</year><volume>96</volume><fpage>1301</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1007/s00253-012-4490-5</pub-id><?supplied-pmid 23070651?><pub-id pub-id-type="pmid">23070651</pub-id></element-citation></ref><ref id="B60-antibiotics-07-00041"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrus</surname><given-names>M.L.</given-names></name><name><surname>van Veluw</surname><given-names>G.J.</given-names></name><name><surname>Wosten</surname><given-names>H.A.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name></person-group><article-title>Sorting of streptomyces cell pellets using a complex object parametric analyzer and sorter</article-title><source>J. Vis. Exp.</source><year>2014</year><fpage>e51178</fpage><pub-id pub-id-type="doi">10.3791/51178</pub-id><?supplied-pmid 24561666?><pub-id pub-id-type="pmid">24561666</pub-id></element-citation></ref><ref id="B61-antibiotics-07-00041"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willemse</surname><given-names>J.</given-names></name><name><surname>Buke</surname><given-names>F.</given-names></name><name><surname>van Dissel</surname><given-names>D.</given-names></name><name><surname>Grevink</surname><given-names>S.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>Sparticle, an algorithm for the analysis of filamentous microorganisms in submerged cultures</article-title><source>Antonie Van Leeuwenhoek</source><year>2017</year><fpage>171</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1007/s10482-017-0939-y</pub-id></element-citation></ref><ref id="B62-antibiotics-07-00041"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celler</surname><given-names>K.</given-names></name><name><surname>Cristian</surname><given-names>P.</given-names></name><name><surname>van Loosdrecht</surname><given-names>M.C.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>Structured morphological modeling as a framework for rational strain design of streptomyces species</article-title><source>Antonie Van Leeuwenhoek</source><year>2012</year><volume>102</volume><fpage>409</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1007/s10482-012-9760-9</pub-id><?supplied-pmid 22718122?><pub-id pub-id-type="pmid">22718122</pub-id></element-citation></ref><ref id="B63-antibiotics-07-00041"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieminen</surname><given-names>L.</given-names></name><name><surname>Webb</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>M.C.</given-names></name><name><surname>Hoskisson</surname><given-names>P.A.</given-names></name></person-group><article-title>A flexible mathematical model platform for studying branching networks: Experimentally validated using the model actinomycete, <italic>Streptomyces coelicolor</italic></article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e54316</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0054316</pub-id><?supplied-pmid 23441147?><pub-id pub-id-type="pmid">23441147</pub-id></element-citation></ref><ref id="B64-antibiotics-07-00041"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dissel</surname><given-names>D.</given-names></name><name><surname>Claessen</surname><given-names>D.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>Morphogenesis of streptomyces in submerged cultures</article-title><source>Adv. Appl. Microbiol.</source><year>2014</year><volume>89</volume><fpage>1</fpage><lpage>45</lpage><?supplied-pmid 25131399?><pub-id pub-id-type="pmid">25131399</pub-id></element-citation></ref><ref id="B65-antibiotics-07-00041"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>K.J.</given-names></name><name><surname>Lee</surname><given-names>S.I.</given-names></name><name><surname>Gwak</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>T.W.</given-names></name><name><surname>Choi</surname><given-names>H.J.</given-names></name><name><surname>Jang</surname><given-names>J.Y.</given-names></name><name><surname>Choi</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>C.J.</given-names></name><etal/></person-group><article-title>Optimization of herbicidin a production in submerged culture of streptomyces scopuliridis m40</article-title><source>J. Microbiol. Biotechnol.</source><year>2017</year><volume>27</volume><fpage>947</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.4014/jmb.1611.11005</pub-id><?supplied-pmid 28237998?><pub-id pub-id-type="pmid">28237998</pub-id></element-citation></ref><ref id="B66-antibiotics-07-00041"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dissel</surname><given-names>D.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>Morphology-driven downscaling of streptomyces lividans to micro-cultivation</article-title><source>Antonie Van Leeuwenhoek</source><year>2017</year><fpage>457</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1007/s10482-017-0967-7</pub-id></element-citation></ref><ref id="B67-antibiotics-07-00041"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigali</surname><given-names>S.</given-names></name><name><surname>Nothaft</surname><given-names>H.</given-names></name><name><surname>Noens</surname><given-names>E.E.</given-names></name><name><surname>Schlicht</surname><given-names>M.</given-names></name><name><surname>Colson</surname><given-names>S.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M.</given-names></name><name><surname>Joris</surname><given-names>B.</given-names></name><name><surname>Koerten</surname><given-names>H.K.</given-names></name><name><surname>Hopwood</surname><given-names>D.A.</given-names></name><name><surname>Titgemeyer</surname><given-names>F.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>The sugar phosphotransferase system of <italic>Streptomyces coelicolor</italic> is regulated by the gntr-family regulator dasr and links n-acetylglucosamine metabolism to the control of development</article-title><source>Mol. Microbiol.</source><year>2006</year><volume>61</volume><fpage>1237</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05319.x</pub-id><?supplied-pmid 16925557?><pub-id pub-id-type="pmid">16925557</pub-id></element-citation></ref><ref id="B68-antibiotics-07-00041"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigali</surname><given-names>S.</given-names></name><name><surname>Titgemeyer</surname><given-names>F.</given-names></name><name><surname>Barends</surname><given-names>S.</given-names></name><name><surname>Mulder</surname><given-names>S.</given-names></name><name><surname>Thomae</surname><given-names>A.W.</given-names></name><name><surname>Hopwood</surname><given-names>D.A.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>Feast or famine: The global regulator dasr links nutrient stress to antibiotic production by streptomyces</article-title><source>EMBO Rep.</source><year>2008</year><volume>9</volume><fpage>670</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/embor.2008.83</pub-id><?supplied-pmid 18511939?><pub-id pub-id-type="pmid">18511939</pub-id></element-citation></ref><ref id="B69-antibiotics-07-00041"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yague</surname><given-names>P.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name><name><surname>Simon</surname><given-names>A.</given-names></name><name><surname>Diaz-Garcia</surname><given-names>M.E.</given-names></name><name><surname>Sanchez</surname><given-names>J.</given-names></name></person-group><article-title>New method for monitoring programmed cell death and differentiation in submerged streptomyces cultures</article-title><source>Appl. Environ. Microbiol.</source><year>2010</year><volume>76</volume><fpage>3401</fpage><lpage>3404</lpage><pub-id pub-id-type="doi">10.1128/AEM.00120-10</pub-id><?supplied-pmid 20348294?><pub-id pub-id-type="pmid">20348294</pub-id></element-citation></ref><ref id="B70-antibiotics-07-00041"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yague</surname><given-names>P.</given-names></name><name><surname>Lopez-Garcia</surname><given-names>M.T.</given-names></name><name><surname>Rioseras</surname><given-names>B.</given-names></name><name><surname>Sanchez</surname><given-names>J.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name></person-group><article-title>Pre-sporulation stages of streptomyces differentiation: State-of-the-art and future perspectives</article-title><source>FEMS Microbiol. Lett.</source><year>2013</year><volume>342</volume><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1111/1574-6968.12128</pub-id><?supplied-pmid 23496097?><pub-id pub-id-type="pmid">23496097</pub-id></element-citation></ref><ref id="B71-antibiotics-07-00041"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Innes</surname><given-names>C.M.</given-names></name><name><surname>Allan</surname><given-names>E.J.</given-names></name></person-group><article-title>Induction, growth and antibiotic production of streptomyces viridifaciens l-form bacteria</article-title><source>J. Appl. Microbiol.</source><year>2001</year><volume>90</volume><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2001.01243.x</pub-id><?supplied-pmid 11298223?><pub-id pub-id-type="pmid">11298223</pub-id></element-citation></ref><ref id="B72-antibiotics-07-00041"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kealey</surname><given-names>C.</given-names></name><name><surname>Creaven</surname><given-names>C.A.</given-names></name><name><surname>Murphy</surname><given-names>C.D.</given-names></name><name><surname>Brady</surname><given-names>C.B.</given-names></name></person-group><article-title>New approaches to antibiotic discovery</article-title><source>Biotechnol. Lett.</source><year>2017</year><volume>39</volume><fpage>805</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1007/s10529-017-2311-8</pub-id><?supplied-pmid 28275884?><pub-id pub-id-type="pmid">28275884</pub-id></element-citation></ref><ref id="B73-antibiotics-07-00041"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Piao</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Jia</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Xiang</surname><given-names>W.</given-names></name></person-group><article-title><italic>Streptomyces formicae</italic> sp. Nov., a novel actinomycete isolated from the head of <italic>Camponotus japonicus</italic> mayr</article-title><source>Antonie Van Leeuwenhoek</source><year>2016</year><volume>109</volume><fpage>253</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1007/s10482-015-0628-7</pub-id><?supplied-pmid 26608172?><pub-id pub-id-type="pmid">26608172</pub-id></element-citation></ref><ref id="B74-antibiotics-07-00041"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarmiento-Vizcaino</surname><given-names>A.</given-names></name><name><surname>Brana</surname><given-names>A.F.</given-names></name><name><surname>Gonzalez</surname><given-names>V.</given-names></name><name><surname>Nava</surname><given-names>H.</given-names></name><name><surname>Molina</surname><given-names>A.</given-names></name><name><surname>Llera</surname><given-names>E.</given-names></name><name><surname>Fiedler</surname><given-names>H.P.</given-names></name><name><surname>Rico</surname><given-names>J.M.</given-names></name><name><surname>Garcia-Florez</surname><given-names>L.</given-names></name><name><surname>Acuna</surname><given-names>J.L.</given-names></name><etal/></person-group><article-title>Atmospheric dispersal of bioactive <italic>Streptomyces albidoflavus</italic> strains among terrestrial and marine environments</article-title><source>Microb. Ecol.</source><year>2016</year><volume>71</volume><fpage>375</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1007/s00248-015-0654-z</pub-id><?supplied-pmid 26224165?><pub-id pub-id-type="pmid">26224165</pub-id></element-citation></ref><ref id="B75-antibiotics-07-00041"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarmiento-Vizcaino</surname><given-names>A.</given-names></name><name><surname>Gonzalez</surname><given-names>V.</given-names></name><name><surname>Brana</surname><given-names>A.F.</given-names></name><name><surname>Palacios</surname><given-names>J.J.</given-names></name><name><surname>Otero</surname><given-names>L.</given-names></name><name><surname>Fernandez</surname><given-names>J.</given-names></name><name><surname>Molina</surname><given-names>A.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Vazquez</surname><given-names>F.</given-names></name><name><surname>Acuna</surname><given-names>J.L.</given-names></name><etal/></person-group><article-title>Pharmacological potential of phylogenetically diverse actinobacteria isolated from deep-sea coral ecosystems of the submarine aviles canyon in the cantabrian sea</article-title><source>Microb. Ecol.</source><year>2017</year><volume>73</volume><fpage>338</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1007/s00248-016-0845-2</pub-id><?supplied-pmid 27614749?><pub-id pub-id-type="pmid">27614749</pub-id></element-citation></ref><ref id="B76-antibiotics-07-00041"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schniete</surname><given-names>J.K.</given-names></name><name><surname>Cruz-Morales</surname><given-names>P.</given-names></name><name><surname>Selem-Mojica</surname><given-names>N.</given-names></name><name><surname>Fernandez-Martinez</surname><given-names>L.T.</given-names></name><name><surname>Hunter</surname><given-names>I.S.</given-names></name><name><surname>Barona-Gomez</surname><given-names>F.</given-names></name><name><surname>Hoskisson</surname><given-names>P.A.</given-names></name></person-group><article-title>Expanding primary metabolism helps generate the metabolic robustness to facilitate antibiotic biosynthesis in streptomyces</article-title><source>MBio</source><year>2018</year><volume>9</volume><pub-id pub-id-type="doi">10.1128/mBio.02283-17</pub-id><?supplied-pmid 29437921?><pub-id pub-id-type="pmid">29437921</pub-id></element-citation></ref><ref id="B77-antibiotics-07-00041"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cihak</surname><given-names>M.</given-names></name><name><surname>Kamenik</surname><given-names>Z.</given-names></name><name><surname>Smidova</surname><given-names>K.</given-names></name><name><surname>Bergman</surname><given-names>N.</given-names></name><name><surname>Benada</surname><given-names>O.</given-names></name><name><surname>Kofronova</surname><given-names>O.</given-names></name><name><surname>Petrickova</surname><given-names>K.</given-names></name><name><surname>Bobek</surname><given-names>J.</given-names></name></person-group><article-title>Secondary metabolites produced during the germination of <italic>Streptomyces coelicolor</italic></article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>2495</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.02495</pub-id><?supplied-pmid 29326665?><pub-id pub-id-type="pmid">29326665</pub-id></element-citation></ref><ref id="B78-antibiotics-07-00041"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Wen</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Caiyin</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>Strain improvement of streptomyces roseosporus for daptomycin production by rational screening of he-ne laser and NTG induced mutants and kinetic modeling</article-title><source>Appl. Biochem. Biotechnol.</source><year>2011</year><volume>163</volume><fpage>729</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1007/s12010-010-9078-x</pub-id><?supplied-pmid 20886375?><pub-id pub-id-type="pmid">20886375</pub-id></element-citation></ref><ref id="B79-antibiotics-07-00041"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakeman</surname><given-names>D.L.</given-names></name><name><surname>Graham</surname><given-names>C.L.</given-names></name><name><surname>Young</surname><given-names>W.</given-names></name><name><surname>Vining</surname><given-names>L.C.</given-names></name></person-group><article-title>Culture conditions improving the production of jadomycin b</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2006</year><volume>33</volume><fpage>767</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1007/s10295-006-0113-4</pub-id><?supplied-pmid 16568271?><pub-id pub-id-type="pmid">16568271</pub-id></element-citation></ref><ref id="B80-antibiotics-07-00041"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>H.B.</given-names></name><name><surname>Bethe</surname><given-names>B.</given-names></name><name><surname>Hofs</surname><given-names>R.</given-names></name><name><surname>Zeeck</surname><given-names>A.</given-names></name></person-group><article-title>Big effects from small changes: Possible ways to explore nature&#x02019;s chemical diversity</article-title><source>Chembiochem</source><year>2002</year><volume>3</volume><fpage>619</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1002/1439-7633(20020703)3:7&#x0003c;619::AID-CBIC619&#x0003e;3.0.CO;2-9</pub-id><pub-id pub-id-type="pmid">12324995</pub-id></element-citation></ref><ref id="B81-antibiotics-07-00041"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bursy</surname><given-names>J.</given-names></name><name><surname>Kuhlmann</surname><given-names>A.U.</given-names></name><name><surname>Pittelkow</surname><given-names>M.</given-names></name><name><surname>Hartmann</surname><given-names>H.</given-names></name><name><surname>Jebbar</surname><given-names>M.</given-names></name><name><surname>Pierik</surname><given-names>A.J.</given-names></name><name><surname>Bremer</surname><given-names>E.</given-names></name></person-group><article-title>Synthesis and uptake of the compatible solutes ectoine and 5-hydroxyectoine by <italic>Streptomyces coelicolor</italic> A3(2) in response to salt and heat stresses</article-title><source>Appl. Environ. Microbiol.</source><year>2008</year><volume>74</volume><fpage>7286</fpage><lpage>7296</lpage><pub-id pub-id-type="doi">10.1128/AEM.00768-08</pub-id><?supplied-pmid 18849444?><pub-id pub-id-type="pmid">18849444</pub-id></element-citation></ref><ref id="B82-antibiotics-07-00041"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>A.</given-names></name><name><surname>Hobbs</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>C.P.</given-names></name><name><surname>Oliver</surname><given-names>S.G.</given-names></name><name><surname>Butler</surname><given-names>P.R.</given-names></name></person-group><article-title>Environmental signals triggering methylenomycin production by <italic>Streptomyces coelicolor</italic> A3(2)</article-title><source>J. Bacteriol.</source><year>1997</year><volume>179</volume><fpage>5511</fpage><lpage>5515</lpage><pub-id pub-id-type="doi">10.1128/jb.179.17.5511-5515.1997</pub-id><?supplied-pmid 9287007?><pub-id pub-id-type="pmid">9287007</pub-id></element-citation></ref><ref id="B83-antibiotics-07-00041"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medema</surname><given-names>M.H.</given-names></name><name><surname>Alam</surname><given-names>M.</given-names></name><name><surname>Breitling</surname><given-names>R.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name></person-group><article-title>The future of industrial antibiotic production: From random mutagenesis to synthetic biology</article-title><source>Bioeng. Bugs.</source><year>2011</year><fpage>230</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.4161/bbug.2.4.16114</pub-id><pub-id pub-id-type="pmid">21829093</pub-id></element-citation></ref><ref id="B84-antibiotics-07-00041"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y.R.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Qiang</surname><given-names>H.</given-names></name><name><surname>Lin</surname><given-names>W.L.</given-names></name><name><surname>Demain</surname><given-names>A.L.</given-names></name></person-group><article-title>Mutagenesis of the rapamycin producer streptomyces hygroscopicus FC904</article-title><source>J. Antibiot.</source><year>2001</year><volume>54</volume><fpage>967</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.54.967</pub-id><?supplied-pmid 11827040?><pub-id pub-id-type="pmid">11827040</pub-id></element-citation></ref><ref id="B85-antibiotics-07-00041"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Hosaka</surname><given-names>T.</given-names></name><name><surname>Ochi</surname><given-names>K.</given-names></name></person-group><article-title>Dramatic activation of antibiotic production in <italic>Streptomyces coelicolor</italic> by cumulative drug resistance mutations</article-title><source>Appl. Environ. Microbiol.</source><year>2008</year><volume>74</volume><fpage>2834</fpage><lpage>2840</lpage><pub-id pub-id-type="doi">10.1128/AEM.02800-07</pub-id><?supplied-pmid 18310410?><pub-id pub-id-type="pmid">18310410</pub-id></element-citation></ref><ref id="B86-antibiotics-07-00041"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>N.L.</given-names></name><name><surname>Thaker</surname><given-names>M.</given-names></name><name><surname>Koteva</surname><given-names>K.</given-names></name><name><surname>Hughes</surname><given-names>D.W.</given-names></name><name><surname>Wright</surname><given-names>G.D.</given-names></name><name><surname>Nodwell</surname><given-names>J.R.</given-names></name></person-group><article-title>Induction of antimicrobial activities in heterologous streptomycetes using alleles of the <italic>Streptomyces coelicolor</italic> gene absa1</article-title><source>J. Antibiot.</source><year>2010</year><volume>63</volume><fpage>177</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1038/ja.2010.13</pub-id><?supplied-pmid 20224601?><pub-id pub-id-type="pmid">20224601</pub-id></element-citation></ref><ref id="B87-antibiotics-07-00041"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foley</surname><given-names>T.L.</given-names></name><name><surname>Young</surname><given-names>B.S.</given-names></name><name><surname>Burkart</surname><given-names>M.D.</given-names></name></person-group><article-title>Phosphopantetheinyl transferase inhibition and secondary metabolism</article-title><source>FEBS J.</source><year>2009</year><volume>276</volume><fpage>7134</fpage><lpage>7145</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07425.x</pub-id><?supplied-pmid 19895578?><pub-id pub-id-type="pmid">19895578</pub-id></element-citation></ref><ref id="B88-antibiotics-07-00041"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onaka</surname><given-names>H.</given-names></name></person-group><article-title>Biosynthesis of indolocarbazole and goadsporin, two different heterocyclic antibiotics produced by actinomycetes</article-title><source>Biosci. Biotechnol. Biochem.</source><year>2009</year><volume>73</volume><fpage>2149</fpage><lpage>2155</lpage><pub-id pub-id-type="doi">10.1271/bbb.90263</pub-id><?supplied-pmid 19809190?><pub-id pub-id-type="pmid">19809190</pub-id></element-citation></ref><ref id="B89-antibiotics-07-00041"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recio</surname><given-names>E.</given-names></name><name><surname>Colinas</surname><given-names>A.</given-names></name><name><surname>Rumbero</surname><given-names>A.</given-names></name><name><surname>Aparicio</surname><given-names>J.F.</given-names></name><name><surname>Martin</surname><given-names>J.F.</given-names></name></person-group><article-title>Pi factor, a novel type quorum-sensing inducer elicits pimaricin production in streptomyces natalensis</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>41586</fpage><lpage>41593</lpage><pub-id pub-id-type="doi">10.1074/jbc.M402340200</pub-id><?supplied-pmid 15231842?><pub-id pub-id-type="pmid">15231842</pub-id></element-citation></ref><ref id="B90-antibiotics-07-00041"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>S.</given-names></name><name><surname>Ban</surname><given-names>Y.H.</given-names></name><name><surname>Park</surname><given-names>J.W.</given-names></name><name><surname>Yoo</surname><given-names>Y.J.</given-names></name><name><surname>Yoon</surname><given-names>Y.J.</given-names></name></person-group><article-title>Enhanced FK506 production in <italic>Streptomyces clavuligerus</italic> ckd1119 by engineering the supply of methylmalonyl-coa precursor</article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2009</year><volume>36</volume><fpage>1473</fpage><lpage>1482</lpage><pub-id pub-id-type="doi">10.1007/s10295-009-0635-7</pub-id><?supplied-pmid 19756799?><pub-id pub-id-type="pmid">19756799</pub-id></element-citation></ref><ref id="B91-antibiotics-07-00041"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>M.</given-names></name><name><surname>Qian</surname><given-names>J.</given-names></name><name><surname>Zhuang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name></person-group><article-title>Disruption of ZWF2 gene to improve oxytetraclyline biosynthesis in streptomyces rimosus M4018</article-title><source>Wei Sheng Wu Xue Bao</source><year>2008</year><volume>48</volume><fpage>21</fpage><lpage>25</lpage><?supplied-pmid 18338571?><pub-id pub-id-type="pmid">18338571</pub-id></element-citation></ref><ref id="B92-antibiotics-07-00041"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yag&#x000fc;e</surname><given-names>P.</given-names></name><name><surname>Manteca</surname><given-names>A.</given-names></name></person-group><article-title>Optimization of the antibiotic producction in different Streptomyces strains by conditioning the MII differentiation</article-title><year>2018</year><comment>Unpublished results</comment></element-citation></ref><ref id="B93-antibiotics-07-00041"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malla</surname><given-names>S.</given-names></name><name><surname>Niraula</surname><given-names>N.P.</given-names></name><name><surname>Liou</surname><given-names>K.</given-names></name><name><surname>Sohng</surname><given-names>J.K.</given-names></name></person-group><article-title>Self-resistance mechanism in streptomyces peucetius: Overexpression of drra, drrb and drrc for doxorubicin enhancement</article-title><source>Microbiol. Res.</source><year>2010</year><volume>165</volume><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2009.04.002</pub-id><?supplied-pmid 19651502?><pub-id pub-id-type="pmid">19651502</pub-id></element-citation></ref><ref id="B94-antibiotics-07-00041"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Zhuo</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>D.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Bai</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name></person-group><article-title>Overexpression of the abc transporter avtab increases avermectin production in streptomyces avermitilis</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2011</year><volume>92</volume><fpage>337</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1007/s00253-011-3439-4</pub-id><?supplied-pmid 21713508?><pub-id pub-id-type="pmid">21713508</pub-id></element-citation></ref><ref id="B95-antibiotics-07-00041"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Willems</surname><given-names>A.</given-names></name><name><surname>Au-Yeung</surname><given-names>C.</given-names></name><name><surname>Tahlan</surname><given-names>K.</given-names></name><name><surname>Nodwell</surname><given-names>J.R.</given-names></name></person-group><article-title>A two-step mechanism for the activation of actinorhodin export and resistance in <italic>Streptomyces coelicolor</italic></article-title><source>MBio</source><year>2012</year><volume>3</volume><fpage>e00191-12</fpage><pub-id pub-id-type="doi">10.1128/mBio.00191-12</pub-id><?supplied-pmid 23073761?><pub-id pub-id-type="pmid">23073761</pub-id></element-citation></ref><ref id="B96-antibiotics-07-00041"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>N.L.</given-names></name><name><surname>Nodwell</surname><given-names>J.R.</given-names></name></person-group><article-title>Phosphorylated absa2 negatively regulates antibiotic production in <italic>Streptomyces coelicolor</italic> through interactions with pathway-specific regulatory gene promoters</article-title><source>J. Bacteriol.</source><year>2007</year><volume>189</volume><fpage>5284</fpage><lpage>5292</lpage><pub-id pub-id-type="doi">10.1128/JB.00305-07</pub-id><?supplied-pmid 17513473?><pub-id pub-id-type="pmid">17513473</pub-id></element-citation></ref><ref id="B97-antibiotics-07-00041"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Wen</surname><given-names>Y.</given-names></name></person-group><article-title>Li, J. The pathway-specific regulator aver from <italic>Streptomyces avermitilis</italic> positively regulates avermectin production while it negatively affects oligomycin biosynthesis</article-title><source>Mol. Genet. Genomics</source><year>2010</year><volume>283</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1007/s00438-009-0502-2</pub-id><?supplied-pmid 20012992?><pub-id pub-id-type="pmid">20012992</pub-id></element-citation></ref><ref id="B98-antibiotics-07-00041"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Retzlaff</surname><given-names>L.</given-names></name><name><surname>Distler</surname><given-names>J.</given-names></name></person-group><article-title>The regulator of streptomycin gene expression, strr, of streptomyces griseus is a DNA binding activator protein with multiple recognition sites</article-title><source>Mol. Microbiol.</source><year>1995</year><volume>18</volume><fpage>151</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.1995.mmi_18010151.x</pub-id><?supplied-pmid 8596455?><pub-id pub-id-type="pmid">8596455</pub-id></element-citation></ref><ref id="B99-antibiotics-07-00041"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laureti</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Corre</surname><given-names>C.</given-names></name><name><surname>Leblond</surname><given-names>P.</given-names></name><name><surname>Challis</surname><given-names>G.L.</given-names></name><name><surname>Aigle</surname><given-names>B.</given-names></name></person-group><article-title>Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in <italic>Streptomyces ambofaciens</italic></article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>6258</fpage><lpage>6626</lpage><pub-id pub-id-type="doi">10.1073/pnas.1019077108</pub-id><?supplied-pmid 21444795?><pub-id pub-id-type="pmid">21444795</pub-id></element-citation></ref><ref id="B100-antibiotics-07-00041"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menendez</surname><given-names>N.</given-names></name><name><surname>Brana</surname><given-names>A.F.</given-names></name><name><surname>Salas</surname><given-names>J.A.</given-names></name><name><surname>Mendez</surname><given-names>C.</given-names></name></person-group><article-title>Involvement of a chromomycin abc transporter system in secretion of a deacetylated precursor during chromomycin biosynthesis</article-title><source>Microbiology</source><year>2007</year><volume>153</volume><fpage>3061</fpage><lpage>3070</lpage><pub-id pub-id-type="doi">10.1099/mic.0.2007/007922-0</pub-id><?supplied-pmid 17768249?><pub-id pub-id-type="pmid">17768249</pub-id></element-citation></ref><ref id="B101-antibiotics-07-00041"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunet</surname><given-names>R.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Mendes</surname><given-names>M.V.</given-names></name><name><surname>Corre</surname><given-names>C.</given-names></name><name><surname>Hotel</surname><given-names>L.</given-names></name><name><surname>Rouhier</surname><given-names>N.</given-names></name><name><surname>Framboisier</surname><given-names>X.</given-names></name><name><surname>Leblond</surname><given-names>P.</given-names></name><name><surname>Challis</surname><given-names>G.L.</given-names></name><name><surname>Aigle</surname><given-names>B.</given-names></name></person-group><article-title>Characterization and manipulation of the pathway-specific late regulator alpw reveals <italic>Streptomyces ambofaciens</italic> as a new producer of kinamycins</article-title><source>J. Bacteriol.</source><year>2010</year><pub-id pub-id-type="doi">10.1128/JB.01269-10</pub-id><?supplied-pmid 21193612?><pub-id pub-id-type="pmid">21193612</pub-id></element-citation></ref><ref id="B102-antibiotics-07-00041"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Escribano</surname><given-names>J.P.</given-names></name><name><surname>Bibb</surname><given-names>M.J.</given-names></name></person-group><article-title>Engineering <italic>Streptomyces coelicolor</italic> for heterologous expression of secondary metabolite gene clusters</article-title><source>Microb. Biotechnol.</source><year>2011</year><volume>4</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1111/j.1751-7915.2010.00219.x</pub-id><?supplied-pmid 21342466?><pub-id pub-id-type="pmid">21342466</pub-id></element-citation></ref><ref id="B103-antibiotics-07-00041"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>M.</given-names></name><name><surname>Uchiyama</surname><given-names>T.</given-names></name><name><surname>Omura</surname><given-names>S.</given-names></name><name><surname>Cane</surname><given-names>D.E.</given-names></name><name><surname>Ikeda</surname><given-names>H.</given-names></name></person-group><article-title>Genome-minimized streptomyces host for the heterologous expression of secondary metabolism</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>2646</fpage><lpage>2651</lpage><pub-id pub-id-type="doi">10.1073/pnas.0914833107</pub-id><?supplied-pmid 20133795?><pub-id pub-id-type="pmid">20133795</pub-id></element-citation></ref><ref id="B104-antibiotics-07-00041"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novakova</surname><given-names>R.</given-names></name><name><surname>Nunez</surname><given-names>L.E.</given-names></name><name><surname>Homerova</surname><given-names>D.</given-names></name><name><surname>Knirschova</surname><given-names>R.</given-names></name><name><surname>Feckova</surname><given-names>L.</given-names></name><name><surname>Rezuchova</surname><given-names>B.</given-names></name><name><surname>Sevcikova</surname><given-names>B.</given-names></name><name><surname>Menendez</surname><given-names>N.</given-names></name><name><surname>Moris</surname><given-names>F.</given-names></name><name><surname>Cortes</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Increased heterologous production of the antitumoral polyketide mithramycin a by engineered streptomyces lividans TK24 strains</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2018</year><volume>102</volume><fpage>857</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1007/s00253-017-8642-5</pub-id><?supplied-pmid 29196786?><pub-id pub-id-type="pmid">29196786</pub-id></element-citation></ref><ref id="B105-antibiotics-07-00041"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>T.</given-names></name><name><surname>Izumikawa</surname><given-names>M.</given-names></name><name><surname>Kozone</surname><given-names>I.</given-names></name><name><surname>Hashimoto</surname><given-names>J.</given-names></name><name><surname>Kagaya</surname><given-names>N.</given-names></name><name><surname>Koiwai</surname><given-names>H.</given-names></name><name><surname>Komatsu</surname><given-names>M.</given-names></name><name><surname>Fujie</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>N.</given-names></name><name><surname>Ikeda</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Neothioviridamide, a polythioamide compound produced by heterologous expression of a <italic>Streptomyces</italic> sp. Cryptic ripp biosynthetic gene cluster</article-title><source>J. Nat. Prod.</source><year>2018</year><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00607</pub-id><?supplied-pmid 29381067?><pub-id pub-id-type="pmid">29381067</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="antibiotics-07-00041-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><italic>Streptomyces</italic> growth in solid cultures (<bold>upper panels</bold>) and liquid cultures (<bold>lower panels</bold>). In solid cultures (petri plates), spores germinate developing a compartmentalised mycelium (early substrate mycelium, MI) with 1 &#x000b5;m average cross-membrane spacing [<xref rid="B6-antibiotics-07-00041" ref-type="bibr">6</xref>]. Some of the MI cells suffer a first round of programmed cell death PCD (red segments). The remaining viable segments start to grow as a multinucleated mycelium with sporadic septa (early MII, late substrate mycelium) [<xref rid="B6-antibiotics-07-00041" ref-type="bibr">6</xref>]. The mycelium substrate suffers a second round of PCD (red segments) and differentiates into a mycelium that starts to grow into the air (the medium/agar border is indicated by a brown line) (late MII, aerial mycelium). Part of the aerial hyphae form spore chains (black circles). In liquid cultures, there is germination, MI development, PCD (in the centre of the mycelial pellets) and MII differentiation (in the periphery of the pellets). In most species, there is no aerial mycelium formation or sporulation, and hyphae form pellets and clumps [<xref rid="B2-antibiotics-07-00041" ref-type="bibr">2</xref>]. Secondary metabolites (outlined as yellow circles and blue starts) are produced by the MII hyphae.</p></caption><graphic xlink:href="antibiotics-07-00041-g001"/></fig><table-wrap id="antibiotics-07-00041-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-07-00041-t001_Table 1</object-id><label>Table 1</label><caption><p>Non-specific methods and some successful examples of their enforcement. &#x0201c;Enhance&#x0201d; means an improvement in production; &#x0201c;cryptic&#x0201d; means activation of the expression of cryptic pathways.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Methods</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Microorganism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Product</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effect</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Media manipulation</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. roseosporus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Daptomycin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-antibiotics-07-00041" ref-type="bibr">78</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Stress Response</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. venezuelae</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Jadomycin B</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B79-antibiotics-07-00041" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. hygroscopicus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Validamycin A</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B21-antibiotics-07-00041" ref-type="bibr">21</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. parvulus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Manumycin family</td><td align="center" valign="middle" rowspan="1" colspan="1">Cryptic</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B80-antibiotics-07-00041" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ectoine, 5-hydroxyectoine</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B81-antibiotics-07-00041" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methylenomycin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-antibiotics-07-00041" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>One Strain Many Compounds (</bold><bold>OSMAC)</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. parvulus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 cryptic compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-antibiotics-07-00041" ref-type="bibr">80</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Random Mutagenesis</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. clavuligerus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Clavulanic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B83-antibiotics-07-00041" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. hygroscopicus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Rapamycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B84-antibiotics-07-00041" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Actinorhodin, Undecylprodigiosin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-antibiotics-07-00041" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Ribosomal Engineering</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Actinorhodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-antibiotics-07-00041" ref-type="bibr">85</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Engineering Global Regulation</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Actinorhodin, Prodigiosin, Calcium-Dependent Antibiotic</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B86-antibiotics-07-00041" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. griseus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Streptomycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B86-antibiotics-07-00041" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. griseochromogenes</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blasticidin S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-antibiotics-07-00041" ref-type="bibr">86</xref>]</td></tr><tr><td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Elicitors</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Actinorhodin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B87-antibiotics-07-00041" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. pristinaespiralis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Desferrioxamine B/E</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B20-antibiotics-07-00041" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. peucetius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Doxorubicin, Baumycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B20-antibiotics-07-00041" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Actinorhodin, Undecylprodigiosin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B68-antibiotics-07-00041" ref-type="bibr">68</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. lividans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Prodiginine</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B88-antibiotics-07-00041" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. griseus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Streptomycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B21-antibiotics-07-00041" ref-type="bibr">21</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. natalensis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Pimaricin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B89-antibiotics-07-00041" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29 strains</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptic compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-antibiotics-07-00041" ref-type="bibr">45</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Metabolic Engineering</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. clavuligerus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">FK606</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B90-antibiotics-07-00041" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Actinorhodin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B90-antibiotics-07-00041" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. rimosus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxytetracycline</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B91-antibiotics-07-00041" ref-type="bibr">91</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Co-cultures</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. rimosus</italic> MY02</td><td align="center" valign="middle" rowspan="1" colspan="1">Antifungal activity</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B36-antibiotics-07-00041" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Actinorhodin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-antibiotics-07-00041" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. fradiae 007</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Phenolic polyketides</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-antibiotics-07-00041" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marine <italic>streptomycetes</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">See tables in reference</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-antibiotics-07-00041" ref-type="bibr">39</xref>]</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Conditioning Morphology (PCD + MII)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. cattleya</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Tienamycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B92-antibiotics-07-00041" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. cinereoruber</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Rodomycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Saccharopolyspora erythraea</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Erithromycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Actinorhodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td></tr></tbody></table></table-wrap><table-wrap id="antibiotics-07-00041-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-07-00041-t002_Table 2</object-id><label>Table 2</label><caption><p>Biosynthetic cluster specific methods and some successful examples of their enforcement.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Methods</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Microorganism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Product</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effect</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Engineering Self-Resistance</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. peucetius</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Doxorubicin, Daunorubicin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B93-antibiotics-07-00041" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. avermitilis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Avermectin,</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B94-antibiotics-07-00041" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Actinorhodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-antibiotics-07-00041" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>Regulatory Engineering</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Delete repressor AbsA2~P</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Actinorhodin, Undecylprodigiosin, Calcium-dependent antibiotic</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B96-antibiotics-07-00041" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Overexpress AverR/StrR</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. avermitilis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Avermectin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B97-antibiotics-07-00041" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Overexpress AverR/StrR</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. griseous</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Streptomycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B98-antibiotics-07-00041" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Overexpress SamR0484</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. ambofaciens</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Stambomicin A-D</td><td align="center" valign="middle" rowspan="1" colspan="1">Cryptic</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B99-antibiotics-07-00041" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Delete repressor <italic>cmmRII</italic></td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. griseus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Chromomycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B100-antibiotics-07-00041" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Delete repressor AlpW</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. ambofaciens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alpomycin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-antibiotics-07-00041" ref-type="bibr">101</xref>]</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Heterologous Expression</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. avermitilis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Streptomycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance </td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B102-antibiotics-07-00041" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Chloramphenicol</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance </td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B103-antibiotics-07-00041" ref-type="bibr">103</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. coelicolor</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Congocidine</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B103-antibiotics-07-00041" ref-type="bibr">103</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. cyaneus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">CECT 3335 laccase</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B27-antibiotics-07-00041" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. lividans TK24</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Mithramycin A</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B104-antibiotics-07-00041" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>Streptomyces</italic> sp.</td><td align="center" valign="middle" rowspan="1" colspan="1">Neothioviridamide</td><td align="center" valign="middle" rowspan="1" colspan="1">Cryptic</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B105-antibiotics-07-00041" ref-type="bibr">105</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Several wild-type</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Siamycin-I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-antibiotics-07-00041" ref-type="bibr">29</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Combinatorial Biosynthesis</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. albus J1074</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Novel paulomycin</td><td align="center" valign="middle" rowspan="1" colspan="1">Cryptic</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B31-antibiotics-07-00041" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">See table 1 in ref.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-antibiotics-07-00041" ref-type="bibr">30</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>Conditioning Morphology (PCD + MII)</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. albus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Apigenin, Luteolin</td><td align="center" valign="middle" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B15-antibiotics-07-00041" ref-type="bibr">15</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. mobarensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Microbial transglutaminase </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B14-antibiotics-07-00041" ref-type="bibr">14</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>